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Ovarian follicle growth is a prolonged process that involves progressive development of 
the follicle unit through specific histologically defined stages of development.  Groups around 
the world have begun ovarian cryopreservation programs for young girls and women undergoing 
potentially sterilizing surgery or chemotherapy with the hope that follicles can be isolated from 
these tissues and grown in vitro at a later date.  Though follicles derived from mice can be grown 
up to maturity using conventional culture techniques, scientists have been unsuccessful with the 
in vitro development of follicles from species that have larger follicles.  The objective of this 
study was to develop a culture system that could better support the growth and maturation of 
these larger follicles.  The aims of the study focused on maintaining structural integrity through a 
suspension culture technique, providing three-dimensional support by utilizing an alginate 
microencapsulation technique, and creating a unique oxygen environment that more closely 
mimicked the oxygen levels of the native ovary.  The suspension culture technique was found to 
eliminate follicle flattening that occurred with larger follicles on flat surfaces in a static culture.  
The alginate microencapsulation technique was shown to improve the support of three-
dimensional growth of preantral follicles; but requires the inclusion of FSH in the scaffold in 
order to maintain the growth rate of unencapsulated follicles.  Finally, by implementing a 
dynamic oxygen protocol based on the unique oxygen environment of the ovary, both the yield 
and quality of the oocytes derived from in vitro cultured preantral follicles were significantly 
 iv 
improved when compared to oocytes from follicles cultured at the traditional ambient oxygen 
levels.  In addition, these oocytes were not only able to undergo parthenogenetic activation, but 
were also fertilized through intracytoplasmic sperm injection.  A subsequent gene expression 
analysis uncovered that follicles grown in a high oxygen environment possessed more 
differentially expressed genes compared to an in vivo control than did follicles cultured in a low 
oxygen environment.  Furthermore, these differentially expressed genes were found to regulate 
several key processes that contribute to proper follicular development.  These findings have 
contributed to the development of a novel culture system that has enhanced the in vitro support 
of follicle and oocyte maturation.   
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1.0  INTRODUCTION 
Therapeutic treatments for cancer and other diseases often adversely affect the reproductive cells 
of a patient.  The very therapy that kills the cancer cells also kills the germ cells within the 
reproductive organs.  For girls and women, this is a particularly harsh consequence because 
mammalian females are born with all the eggs they will ever have [1]. Should this original 
complement of eggs be destroyed, the result is sterility.  For adult women, depletion of the 
supply of eggs results in menopause.  Children whose eggs have been destroyed fail to undergo 
puberty.  One step that can be taken to salvage some of the eggs is to remove and freeze the 
ovaries of girls and women prior to their undergoing potentially sterilizing therapies [2].  This 
banked tissue can then be used for transplant back into the patient to restore hormone and egg 
production.  However, the major drawback with this procedure is that re-implanting the ovarian 
tissue carries the very real risk of transferring cancer cells that were resident in the tissue thus re-
introducing the cancer as well [3].  This possibility could be avoided entirely by using the 
preserved tissue as a source of follicles that would be grown to maturity in vitro.  This process 
could then be used as a source of mature oocytes for routine IVF procedures.  The in vitro 
approach has here to fore been limited in that there is currently no technology to produce 
fertilizable eggs from the immature follicles present in the frozen ovaries of most mammals 
including humans. 
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Primordial follicles have a greater likelihood of surviving this cryopreservation [4]. 
Although primordial follicles derived from mice can be grown to maturity using static culture 
techniques [5-7], to date there have been no successful complete in vitro follicle development 
from larger species, such as rats, pigs and humans [8]. Intact rat, primate, or human preantral 
follicles have never been successfully cultured in vitro to maturation.  Successful development of 
a technology in which preserved ovarian tissues can be utilized to restore fertility, would be a 
major development in reproductive science.    
In addition to the potential advances in the area of infertility, the development of a 
successful follicle culture system can potentially become a more efficient source of matured 
oocytes for the derivation of embryonic stem cell lines.  Recently, there has been a debate over 
the availability of the approximately 400,000 frozen embryos stored in IVF clinics across the 
United States for the production of new stem cell lines.  However, of these 400,000 embryos, 
only 2.8% (~11,000) have been designated for research purposes.  Using efficiency estimates for 
current technology, it is estimated that these 11,000 embryos would only successfully produce 
about 275 new stem cell lines [9].  Even this value is thought to be inflated because, more than 
likely, not all of the embryos earmarked for research will be exclusively used to created 
embryonic stem cell lines.  Furthermore, the quality of these stored embryos is generally poor 
due to the fact that the high quality embryos are transferred to the patient during fertility 
treatments, leaving lower quality embryos stored in these banks [9]. 
Preliminary studies demonstrate that under conventional conditions, rat follicles 
frequently undergo flattening and rupture with loss of anatomic integrity that is important to the 
normal egg maturation process. When follicles were cultured in suspension culture systems, the 
follicles did not rupture and exhibited more robust growth. Furthermore, we discovered that by 
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utilizing a dynamic oxygen protocol in which the oxygen tension in the incubator is set to mimic 
the in vivo environment of the ovary, preantral rat follicles were matured to produce oocytes that 
resume meiosis and progress to the extrusion of the first polar body. Therefore, we believe that 
advances in bioreactor technologies hold great promise toward the development of a system that 
can support the complex needs of the developing follicle.  This also could provide hope for 
young cancer patients to retain fertility.  More generally, the problems associated with nurturing 
the development of the follicle mirror many of the unmet challenges in tissue engineering as a 
whole. 
Our hypothesis is that follicle development and oocyte maturation will occur more 
efficiently in culture by providing metabolic support that more closely mimics the in vivo 
environment of the ovary. 
The goal of this dissertation is to use a novel suspension culture system to support 
follicles into later stages of development.  We propose that a suspension culture system can 
better support the metabolic and structural needs of the developing follicle.  By optimizing the 
oxygen tension levels of the culture system and the three dimensional support of the follicle, we 
will answer basic biological questions regarding early follicle development and provide the basis 
for the prolonged growth of mammalian follicles and maturation of oocytes.  Further, the use of 
such systems to generate embryonic stem cells could have far reaching effects on tissue 
engineering and regenerative medicine.  Based upon these areas of research, the aims for the 
present study were as follows:  
 
Specific Aim 1: Determine the effect of structural support, nutrient delivery, and 
mechanical shear stress on follicular growth and morphology.  We hypothesized that, by 
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culturing follicles in a suspension culture system, the three-dimensional integrity of the follicular 
unit would be better supported.  Furthermore, the utilization of alginate microcapsules could help 
maintain proper follicle morphology.  In order to test this hypothesis, preantral ovarian follicles 
from Sprague Dawley rats were cultured in either of three different techniques, static culture in 
96-well plates, orbiting test tubes, or rotating-wall vessels.  Furthermore, additional follicles 
were cultured in suspension after being encapsulated in alginate microcapsules.  Structural 
integrity was measured by the proportion of follicles that underwent follicular flattening, while 
morphology was assessed by histology and subsequent staining for gap junction proteins. 
 
Specific Aim 2: Determine the effect of a dynamic oxygen delivery protocol that more 
closely mimicked the oxygen environment of the native ovary on oocyte viability and 
maturation.  We hypothesized that the difficulty in achieving in vitro oocyte maturation may be 
due to the dysregulation of follicle development by exposure of early stage follicles to 
inappropriate oxygen concentrations.  It is likely that in vivo follicles experience a transition 
from relative hypoxia in early development to the high volume of blood flow and oxygen 
delivery for pre-ovulatory follicles.  This hypothesis was tested by culturing preantral follicles 
from Sprague Dawley rats in the orbiting test tube suspension culture system from aim 1 under 
two different oxygen regimens, ambient oxygen concentration throughout the duration of the 
culture or a dynamic oxygen environment in which the oxygen concentration was increased 
throughout the culture period.  Oocyte viability was determined visually and oocyte maturation 
was determined by whether the oocyte was able to resume meiosis and undergo germinal vesicle 
breakdown.  Oocyte maturation was further explored by comparing the efficiency of each group 
to produce oocytes capable of undergoing parthenogenetic activation. 
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 Specific Aim 3: Determine the effect of oxygen concentration on preantral follicle gene 
expression.  We hypothesized that by placing the follicles in the ambient oxygen group in an 
environment more suitable to mature graafian follicles, the granulosa cells may not differentiate 
properly, leading to desynchronized follicle development.  This hypothesis was tested by 
culturing preantral follicles from Sprague Dawley rats for 3 days at two different oxygen 
concentrations, 4% or 20%.  The gene expression pattern for these two culture groups along with 
an in vivo control group were obtained from analyzing the mRNA of each group on whole rat 
genome expression beadchips.  Differentiated genes were then analyzed to determine if any 
could play a role in altering proper preantral follicle development. 
1.1 OVARIAN ANATOMY AND PHYSIOLOGY 
In the human female, the ovaries lie in the posterior wall of the pelvis in depressions known as 
the ovarian fossa (Figure1).  Each ovary measures approximately 4cm in length, 2cm in width, 
and 8mm in thickness [10].   
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 Figure 1: Uterus and right broad ligament, seen from behind. The broad ligament has been spread out and the ovary 
drawn downward. Reprinted from [10].  
 
The outer surface of the organ is comprised of an epithelial cell layer known as the 
germinal epithelium of Waldeyer.  Encapsulated by this epithelial layer is the ovarian stroma, 
which constitutes the bulk of the ovary.  The stroma is divided into two regions, the cortex and 
the medulla (Figure 2).  The external surface of the cortex is condensed, forming a thin layer of 
connective-tissue fibers known as the tunica albuginea.  The stroma then transitions to a softer 
tissue composed of spindle-shaped cells as the connective tissue becomes less dense throughout 
the more interior regions of the cortex.  The medulla is the most interior portion of the stroma.  It 
is highly vascularized and forms the hilum, the tissue that attaches the ovary and through which 
the blood vessels enter [10].  
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 Figure 2: Section of the ovary. 1. Outer covering. 1’. Attached border. 2. Central stroma. 3. Peripheral stroma. 4. 
Blood vessels. 5. Vesicular follicles in their earliest stage. 6, 7, 8. More advanced follicles. 9. An almost mature 
follicle. 9’. Follicle from which the ovum has escaped. 10. Corpus luteum. Reprinted from [10]. 
 
The main functional unit of the ovary is the spherical follicle (Figure 3).  In viewing a 
section of the ovary, the follicles are present throughout the entire stroma.  The smaller immature 
follicles are located in the external cortical layer, while the more mature follicles increase in size 
as they move towards the highly vascularized medullary substance in the center of the ovary 
[10].  Throughout the cortical region, blood vessels are rarely observed in close proximity to any 
of the primordial or primary follicles [11].  In contrast, an abundance of blood vessels are found 
in the interior medullary region surrounding the secondary and antral follicles [11].  
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Figure 3: Anatomy of a Preantral Follicle. 
 
Follicles consist of an oocyte surrounded by epithelial-like granulosa cells.  The 
granulosa cells are surrounded by a basement membrane.  Outside the basement membrane is a 
mesenchymal layer of cells called theca cells [1].  Follicles generally exist in a resting pool, in a 
relatively inert stage.  An unknown mechanism results in the activation and growth of some 
follicles, while the majority of the follicle complement remains in the resting pool.  When 
follicles are recruited from the resting pool, they grow independently through morphologically 
distinct stages known in order as, primordial, primary, secondary, preantral, antral, and Graafian 
[1].   
Follicles develop through primordial, primary and secondary or preantral stages before 
acquiring an antral cavity, a fluid-filled cavity within the follicle.  The fate of the vast majority of 
antral follicles is atresia, the degeneration of a follicle prior to maturity, via apoptosis [12]. Prior 
to puberty, follicles do not progress past the antral stage.  At puberty the cyclic secretion of 
pituitary follicle stimulating hormone (FSH) and luteinizing hormone (LH) begins [1].  These 
hormones are necessary for the final stages of follicle growth and ovulation as well as 
stimulating the follicular estrogen production responsible for the physical changes of puberty.  
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After puberty, each month a few follicles are rescued from atresia by cyclic gonadotropins and 
go on to become pre-ovulatory follicles [1].  After a complex selection process, one of these 
follicles ovulates, releasing the egg, and transforms into a corpus luteum.  Well over half of the 
time of folliculogenesis occurs prior to the antral stage of development.  Unfortunately, 
knowledge about regulatory events during the prolonged developmental period of early follicles 
is very limited because it has not been possible to culture these early follicles over the prolonged 
course of development. 
The oocytes develop within the ovaries through a process known as oogenesis.  For 
humans, the germ cells have progressed from a primitive oogonia present throughout fetal 
development into what are known as primary oocytes at birth [10].  These primary oocytes 
possess the full compliment of 46 chromosomes and begin to replicate their DNA as they enter 
the first meiotic division.  However, meiosis is arrested in the midst of prophase and the primary 
oocytes will remain in this state until puberty is reached [10].   
At the onset of puberty, follicle stimulating hormone is produced and released by the 
pituitary.  In response to FSH, several follicles are selected each month and begin to grow.  As 
the follicles grow, factors are released that promote oocyte growth and development.  One 
follicle will eventually become dominant over the other selected follicles and progress to become 
a graffian follicle.  The oocyte contained within the maturing follicle is triggered to resume 
meiosis I (Figure 4).  At this stage, the oocyte undergoes the first meiotic division, in which half 
of the chromosomes (46) go into a small cell known as the first polar body and the other half 
(46) stays within a larger cell that contains the vast majority of the cytoplasm and organelles 
from the original primary oocyte [10].  This larger cell is the secondary oocyte.  Both of the 
resulting cells are diploid.  The secondary oocyte then begins the second meiotic division, but 
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arrests during metaphase.  At this point that ovulation occurs.  The secondary oocyte will remain 
in this state until fertilization or the cell degenerates. 
 
Figure 4: Diagram showing the reduction in number of the chromosomes in the process of maturation of the ovum. 
Reprinted from [10] 
     
If fertilization is achieved, the secondary oocyte will resume meiosis II.  Similar to the 
first division, the second meiotic division results in half the chromosomes (23) going into a 
second small polar body while the other half (23) remain in the much larger ovum with the 
cytoplasm and organelles [10].  This division results in two haploid cells, the second polar body 
and the ovum which will possess a maternal pronucleus containing 23 chromosomes (Figure 4).  
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Eventually, the paternal pronucleus from the sperm, also containing 23 chromosomes, will 
combine with the maternal pronucleus and form a zygote. 
1.2 EFFECTS OF CHEMO AND RADIATION THERAPY 
In the late 1970’s, the 5-year survival rate for children treated for leukaemia was 33% [13].  By 
the early 1990’s, that figure rose to 80% due to improvements in chemotherapy regimens and 
radiation therapy technology [14].  Thirty years ago, patients were lucky to be alive.  Today, 
however, the outlook for young cancer patients is to have a normal reproductive life-span.  As a 
result of this success, research is focusing on the need to address the significant morbidity 
associated with these treatments.   
Chemotherapy refers to a type of treatment in which a chemical agent or a series of 
chemical agents are used to target cancerous cells.  These chemical agents have the ability to 
inhibit cell division and cause cell death in dividing cells [13].  In the treatment of cancer, this is 
advantageous in that tumor cells are fast-dividing, so these drugs will in effect target these 
diseased cells.  However, scientists have yet to develop a drug that specifically targets cancerous 
cells only.  As a result, the chemotherapy agent can damage healthy cells as well, such as the 
fast-dividing cells within the hair follicles.   
Radiation therapy refers to the use of ionizing radiation to manage malignant cells.  In 
this method, an ion beam either directly or indirectly ionizes the atoms that comprise the DNA 
chain, thus damaging the DNA of the cell.  In most cases, the ion beam ionizes water, forming 
free radicals, which will then damage the DNA.  In the treatment of cancer, this technology is 
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used to both treat specific tumors and can be used for total body irradiation which prepares the 
patient for a bone marrow transplant [13]. 
Both treatments can result in ovarian toxicity.  In the case of curative chemotherapy, 
germ-cell damage and ovarian failure is a common long-term side effect [13].  Studies have 
shown that older women are at greater risk of ovarian failure than younger women undergoing 
the same treatment [15, 16].  Furthermore, the class of chemotherapy agent can also affect the 
level of risk for ovarian tissue damage [13].  There are five classes of chemotherapy drugs: 
alkylating agents, aneuploidy inducers, topoisomerase II inhibitors, antimetabolites and 
radiomimetics.  In most cases, a combination of these agents is used.   
In the case of ovarian follicles, it was found that alkylating agents resulted in the greatest 
risk of causing ovarian failure [13].  These follicles, especially the primordial follicles, are quite 
susceptible to these chemotherapeutic agents.  In an in vitro study with the chemotherapeutic 
agent cisplatin, pregranulosa cell swelling and pregranulosa cell nuclear swelling was observed 
in primordial follicles along with the disappearance of the follicle’s lumen and oocyte [17].  
Positive staining for apoptosis was also present within these cells.  From these results, it was 
determined that chemotherapeutic agents reduce and possibly eliminate the follicle population in 
the ovary by inducing apoptosis in the pregranulosa cells due to the DNA damage caused by the 
agent in those cells [18].        
A similar trend was discovered with radiation therapy.  By directing an ion beam at a 
disease residing in the pelvis, such as cervical cancer, or the entire body, known as total body 
irradiation, the ovaries can be exposed to considerable doses of irradiation [17].  Studies have 
shown that 4 Gy is the approximate dose at which half of the ovarian follicles in a human will 
die [19].  Total body irradiation was found to cause ovarian failure in the majority of women at 
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10 Gy, 14.4 Gy, and using a fractionated 15 Gy protocol [20, 21].  Also, like with chemotherapy, 
the older the patient, the more susceptible their ovaries are to the treatment [21].   
1.3 CRYOPRESERVATION OF OVARIAN TISSUE AND STRATEGIES FOR 
RESTORING FERTILITY  
In response to the detrimental effects of chemotherapy and radiation therapy on the ovarian germ 
cells, researchers have worked to restore fertility through the cryopreservation of ovarian 
material for use after the cancer is successfully treated.  There have been three cryopreservation 
strategies employed to address this problem; the cryopreservation of embryos [22], oocytes [23], 
and ovarian tissue [2, 24]. 
With embryo cryopreservation, patients first undergo hormonal ovarian stimulation 
usually before any potentially harmful cancer treatments are performed.  The eggs are then 
collected and fertilized through a routine in vitro fertilization (IVF) procedure [25].  The 
resulting embryos are then cryogenically stored until needed. 
Although this approach exclusively utilizes standard procedures with well defined 
protocol, there are a number of crucial disadvantages that make the development of an 
alternative method necessary.  For instance, the ovarian stimulation procedure needed to procure 
the requisite number of mature eggs is inappropriate for prepubescent girls, eliminating this 
approach as an option for this group of patients [4].  For those women that this procedure is an 
option, some do not want to use donor sperm and have yet to find their mate.  Furthermore, the 
time required to stimulate and mature the eggs is approximately 6 weeks [4].  In certain cancer 
patients, a delay in treatment this significant is undesirable.  Also, it is theorized that the 
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hormone treatment used to stimulate the ovaries could augment the growth of oestrogen-sensitive 
tumors [4]. 
For these reasons, it became essential to explore the cryopreservation of the gametes 
instead of embryos in order to develop a more practical solution.  One such method is the 
cryopreservation of a patient’s oocytes.  In this approach, mature oocytes could be stored until 
the patient wished to produce an offspring through IVF [23] or immature oocytes could be saved 
until such time they would be matured through in vitro maturation and fertilized through IVF 
[26]. 
For human oocytes, the development of a protocol to successfully and reliably 
cryopreserve mature eggs has yet to be discovered.  Studies have found that the survival rate for 
freeze-thawed mature human oocytes is relatively low [27-29].  Furthermore, the fertilization 
rate for those oocytes that do survive the process is also quite poor [30].  In addition to the 
inefficient recovery and fertilization rates, the cryoprotective solutions have been found to 
damage the microtubules in the meiotic spindle apparatus which aligns the chromosomes in 
metaphase II [27].  The proper function of these microtubules is essential for the appropriate 
separation of the sister chromatids during the second meiotic division that will occur upon 
fertilization.  Improper separation may result in an increased risk of chromosomal abnormalities.   
In contrast, immature oocytes are more resistant to freeze-thaw damage due to their less 
differentiated state [4].  Compared to mature oocytes, immature oocytes have not yet progressed 
to metaphase II.  In these oocytes, the microtubule spindle apparatus is disassembled and the 
chromatin is decondensed and still resides within a nuclear membrane, protecting these features 
from the cryopreservation process [4].  However, the drawback of storing these eggs is that, upon 
thawing, they must be matured in culture before fertilization can occur. 
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Studies have reported in vitro maturation rates that are highly variable and often 
inefficient [28, 31, 32].  It was also found that freeze-thawing oocytes prior to in vitro maturation 
significantly reduced the rate of blastocyst formation [32].  Until a more efficient method to 
mature oocytes in vitro is developed, this will not be a viable option for the preservation of 
fertility. 
The third strategy is to cryopreserve sections of ovarian tissue.  Originally, the goal of 
ovarian tissue cryopreservation was to regain endocrine function in overiectomized rodents.  In 
the 1950’s, researchers developed a protocol in which ovaries were frozen at -79 ˚C in a 
glycerol/saline solution [33-36].  After thawing, this tissue was autologously re-implanted 
subcutaneously in the animal.  It was found that the resumption of oestrous cycles occurred 2-3 
weeks post re-implantation.  As a result of this success, they then attempted to restore fertility in 
these animals by re-implanting the tissue back in its original site.  This protocol did produce 
viable offspring, however, the success rate was relatively low [37].  Although the technology 
was promising, the 1950’s had few applications for it.   
However, as cancer therapies improved, the positive outlook for young cancer patients 
became a catalyst for renewed interest in the technology.  For this application, the preservation 
of ovarian cortex tissue was an ideal strategy.  Not only can this tissue be retrieved by a less 
invasive laparoscopic surgery, but this region of the ovary is where the majority of the primordial 
follicles lie.  This is crucial because it is the primordial follicles that are most likely to survive 
the cryopreservation due to their small size and the undifferentiated state of their cells [4].    
Since the 1950’s, there had also been major advances in cryopreservation technology 
with the advent of the controlled rate freezing apparatus and the development of more effective 
cryoprotective agents.  It was now understood that follicle survival depended on the efficiency of 
 15 
the cryoprotective agent to enter the tissue in order to protect the follicle from freezing damage.  
It was found that agents such as dimethyl sulphoxide, propylene glycol, and ethylene glycol 
significantly increased follicle freeze-thaw survival rates when compared to the previously used 
glycerol supplemented medium (Figure 5) [38].  It is believed that the higher viscosity of the 
glycerol based mediums caused lower permeation rates, resulting in a less effective protective 
agent.  Utilizing this new generation of cryoprotective agents, studies have shown that 
ovariectomized mice implanted with autographed frozen-thawed ovarian tissue demonstrated the 
resumption of oestrous cycles in 75% of the animals and pregnancies were reported in 73% of 
recipients [39]. 
 
 
 
 
Figure 5: The permeation rates of cryoprotective agents: dimethyl sulfoxide (DMSO), ethylene glycol (EG) 
propylene glycol (PROH), and glycerol (GLY). Reprinted from [38] 
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For the purpose of restoring fertility in humans, researchers have developed three broad 
strategies to produce mature eggs from cryopreserved ovarian tissue, autologous re-implantation, 
xenotransplantation into an immunodeficient animal, and the in vitro culture of follicles isolated 
from the ovarian tissue (Figure 6).  Of these methods, only the autologous re-implantation of the 
patient’s banked ovarian tissue either at the orthotopic site or a heterotopic site will serve to 
restore fertility and endocrine function, thus eliminating the need for hormone replacement 
therapy [40].  At the orthotopic site, the patient’s cortical biopsies are sutured into a resected 
ovary prepared laparoscopically prior to the procedure.  Not only will this reestablish the 
patient’s endocrine function, but also restores their ‘natural’ fertility, as matured eggs will be 
released into the fallopian tubes [4].  At a heterotopic site such as the abdominal wall, the re-
implanted tissue would need to be hormonally stimulated and aspirated in order to collect the 
mature eggs and fertilization would then require IVF [41].  
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 Figure 6: Strategies for the restoration of fertility using cryopreserved ovarian tissue. Reprinted from [4] 
 
Although this strategy has the advantage of regaining endocrine function, there are 
significant drawbacks with the procedure.  First, it is unknown how long ovarian function will 
last.  Ovarian function is lost when the follicle population dips below ~ 1,000 [42].  Furthermore, 
it has been found that the follicle depletion rate increases once the total number of follicles hits 
25,000 [42].  Regardless of whether the follicle survival rate is high in the thawed tissue, the 
follicle population in the cortical biopsies is still relatively low.  Therefore, it is likely that 
ovarian function would be restored for only a short duration.   
Second, re-implanting tissue from cancer patients runs the added risk that the biopsies 
would contain malignant cells [43, 44].  This especially is the case for patients with blood-borne 
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cancers like leukaemia or cancers that are known to attack the ovaries.  This has been shown in 
the murine model in which healthy recipients of frozen-thawed ovarian tissue from donors with 
lymphoma had an 85% mortality rate from the transferred malignant disease [3]. 
Xenotransplantation of the ovarian tissue is a strategy that would be less invasive to the 
patient and still provide a vascularized in vivo environment to support the maturation of the 
follicles [45].  With this approach, cortical biopsies are implanted into hypogonadal 
immunodeficient mice.  Hormones are administered exogenously to stimulate follicle growth.  
When the eggs are mature, follicles would be aspirated and the eggs retrieved and fertilized 
through IVF [45].  However, due to ethical and moral issues, this procedure is impractical for 
human application.  Instead, this approach is being explored for use in endangered species 
conservation [4]. 
The final strategy is the in vitro culture of isolated follicles from the frozen-thawed 
ovarian tissue.  In this method, follicles are isolated via manual dissection with syringe needles 
or enzymatic digestion.  The follicles are then placed in culture medium supplemented with FSH 
and a variety of additional components.  Within this strategy there are many culture techniques 
aimed at maturing the follicles.  Researchers have designed techniques that grow follicles on a 
surface, within a microcapsule, and in suspension.  An overview of the different techniques and a 
brief history of the field are outlined in Chapter 1.5.  
One of the advantages of this approach is that, by isolating the follicles, it allows any 
malignant cells present within the cortical biopsy to be removed.  Furthermore, by maturing the 
oocytes in vitro, it eliminates any invasive surgical grafting procedures. 
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1.4 AUTOLOGOUS RE-IMPLANTATION OF CRYOPRESERVED OVARIAN 
TISSUE 
Although there are a variety of approaches to cryopreserving ovarian tissue for transplantation 
back into the patient, the method that has been utilized exclusively in clinical trials to this point 
has been the storage and re-implantation of avascular cortical biopsies [46].  This remains the 
only procedure in humans that has resulted in viable offspring [47].  Currently, there have been 
17 reported attempts to regain endocrine function and fertility through the autotransplantation of 
cryopreserved ovarian tissue at either an orthotopic site (8 cases), a heterotopic site (6 cases), or 
both an orthotopic and a heterotopic site (3 cases).  Table 1 outlines the results of 15 of the trials 
[46]. 
Of the 8 cases in which only an orthotopic site was utilized, 3 resulted in viable 
pregnancies and corresponding live births.  The first successful live birth from cryopreserved 
ovarian tissue was reported in Donnez et al. (2004) [47].  In this case, the patient’s stored tissue 
was thawed and transplanted laproscopically into a pocket surrounding the patient’s ovary 
created a week prior to the surgery.  After 5 months, the patient resumed regular ovulatory cycles 
for 4 months, engaging in natural intercourse, at which point a viable intrauterine pregnancy was 
confirmed.  This pregnancy eventually resulted in a live birth.  Further data, such as whether this 
patient resumed normal ovarian function after the pregnancy, how long it remained, and if the 
cancer returned, has not been reported.   
The second birth was reported a year later in Meirow et al. 2005 [48].  Similar to the 
previous case, the ovarian tissue sections were surgically transplanted at the site of the native 
ovary.  However, in this trial, mature oocytes were collected following hormone injections and 
follicle aspiration.  Using this method, one metaphase II oocyte was retrieved and fertilized via 
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intracytoplasmic sperm injection.  Once it reached the 4-cell stage, the embryo was transferred to 
the patient’s uterus, resulting in a viable pregnancy and a live birth.     
The final case of a live birth was reported from the same group in a manuscript not listed 
in Table 1, Meirow et al. (2007) [49].  The procedure used was identical to their 2005 case 
except that fertilization took place in vitro without the need of intracytoplasmic sperm injection.  
These remain the only three cases that claim a live birth originating from an oocyte from the 
cryopreserved ovarian tissue. 
The remaining 14 cases report results with varying degrees of success in terms of 
regaining endocrine function, retrieving mature oocytes, producing embryos, and inducing 
pregnancies.  With the exception of Oktay (2006) [50], none of the other trials result in a live 
birth.  Furthermore, it was determined that the live birth reported in Oktay (2006) did not 
originate from the transplanted ovarian tissue, but instead was produced by the native ovary.   
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Table 1: Autotransplantation of Cryopreserved Human Ovarian Tissue. Reprinted from [46] 
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As promising as these results are, there are several concerns and questions pertaining to 
this approach.  The first of which questions the validity of the three live births.  In all three cases, 
the source of the fertilized oocyte is not entirely clear.  Each manuscript claims that the oocyte 
originated from the transplanted cryopreserved ovarian tissue.  However, the site of the 
transplant in all three trials was the ovarian cortex or ovarian fossa peritoneum.  Therefore, the 
chance that the oocyte was actually derived from the surrounding native ovarian tissue and not 
the transplanted ovarian tissue cannot be dismissed.   
This concern is further validated with a more in depth analysis of the pregnancy and live 
birth reported in Oktay (2006) [50].  With the transplant location being the abdominal wall, a 
natural pregnancy from that tissue is impossible.  The patient in this study experienced recurrent 
pregnancies, the first resulting in a miscarriage and the second producing the live offspring.  The 
only source for these oocytes was one of the menopausal ovaries.  The mechanism behind the 
spontaneous recovery of ovarian function is unknown.  However, a controversial theory has been 
debated in recent years, which suggests that ovarian tissue transplantation may trigger the 
spontaneous resumption of ovarian function within the native ovary.  Ongoing studies are testing 
the hypothesis, but if this is possible, it would be difficult to conclude with absolute certainty that 
an orthotopic site transplant produced the fertilized oocytes.  Furthermore, this would add 
another factor to the efficacy of the procedure, the degree of damage to the germ cells caused by 
the chemotherapy or radiation therapy. 
A second concern raised from analyzing this data is the high variability in terms of both 
the length of time before the patient regains ovarian function after the transplantation and the 
duration that this function is sustained.  When comparing the Donnez et al. (2004) [47] and 
Radford et al. (2001) [51] reports, the patients suffered identical cancers and were transplanted at 
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the same site.  While the 2004 patient went on to have 5 cycles starting 4.5 months after the 
surgery, the 2001 patient had 1 cycle that occurred 8 months after transplantation.  It should be 
noted that the patients’ age difference could account for the delay and minimal recovery 
observed in the older patient.  However, this suggests that there will be limitations for older 
patients and that this procedure may require a significant amount of tissue at a time when the 
patient will not know if the therapy will even affect their germ cells. 
Finally, almost all of these studies report on a single patient with some degree of success.  
Until there is a more robust clinical trial that can produce a sample population greater than n=1, 
the true efficiency of this strategy will remain unknown. 
1.5 CONVENTIONAL IN VITRO OVARIAN FOLLICLE CULTURE TECHNIQUES 
For three decades, researchers have been attempting to develop a long-term culture technique 
that could support the maturation of oocytes from early stage follicles.  Although this research 
has greatly increased our knowledge and understanding of follicular and oocyte development, the 
creation of viable offspring from oocytes recovered from in vitro cultured preantral follicles has 
only occurred in the mouse [52].  Table 2 outlines the various techniques developed over the 
years [53].  This section will provide a brief history of this technology.   
 
 
 
 
 
 24 
Table 2: Various Approaches to Follicle Culture. Reprinted from [53] 
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1.5.1 Follicle Culture Techniques 
Whole organ culture of the ovary is reserved mostly for small rodents.  It allows for the follicles 
to remain in their native environment, helping maintain three dimensional structure and 
basement membrane integrity as it interacts with the surrounding extracellular matrix [54].  
However, this approach can only be utilized in short-term cultures as necrosis will occur 
throughout the medulla region due to a lack of oxygen and nutrient delivery.  Only the follicles 
located in the outside cortical region of the ovary will be able to survive.   
Although this method cannot fully support the growth of a mature follicle, it has been 
used to initiate the activation of primordial follicles.  The initial studies cultured entire ovaries 
from newborn mice for 8 days, when it was observed that several primordial follicles had 
progressed to secondary preantral follicles [54].  At that point, those follicles were isolated and 
grown individually and eventually produced fertilizable oocytes.  For larger species, the whole 
organ culture is unrealistic, but work continues on using a similar two-step system with ovarian 
tissue strips. 
Another attempt at multiple follicle culturing involves a collection of isolated follicles 
grown within a gel or on top of a surface.  If given the freedom to move, follicles will have a 
tendency to aggregate and grow into one another.   
Individual follicle culture also occurs within gels or on a surface.  Preantral mouse 
follicles will remain spherical and fully mature in a period of approximately 6 days on a tissue 
culture treated surface [52].  The resulting oocytes can be fertilized and have produced viable 
pups.  These results have also been obtained by encapsulating individual mouse follicles in 
hydrogel microcapsules [7].   
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Typically, individual murine follicle cultures will result in roughly 20 % of the follicles 
dying due to physical damage attributed to the isolation technique and a small proportion of the 
remaining follicles undergoing atresia [52, 55].  However, the percentage of follicles that 
respond to the culture and progress through the antral transition, approximately 40-75%, 
significantly surpasses the proportion that reaches this stage in vivo, about 20% [56].   
Although this technique eliminates the necrosis associated with the multiple follicle 
approaches, it has the disadvantage of the follicles flattening out onto the surface they are being 
cultured upon.  This has been found to effect cell-to-cell junctions and causes the cells that plate 
down to alter their morphology [57].   
1.5.2 Follicle Culture Media 
Traditionally, ovarian follicles are cultured in alpha modified minimal essential medium due to 
its ability to properly support rapidly dividing cell types [53].  This is then accompanied with a 
protein source, such as fetal bovine serum (~5%).  Serum supplies various proteins that support 
follicle growth and survival [58].  However, if there is a desire to use a fully defined media, 
insulin, transferrin, and selenium can be substituted [59].  Insulin has been determined to have 
multiple roles during early follicle development.  For preantral follicles, insulin has been found 
to be crucial for follicle survival, increase oocyte growth, and help trigger granulosa cell 
differentiation [60, 61]. 
In addition to these components, a number of hormones are also added to the media in a 
time sensitive manner such as follicle stimulatin hormone (FSH), human chorionic gonadotropin 
(hCG), and luteinizing hormone (LH).  It is known that in vivo follicles transition from the 
primordial to the secondary preantral stage without the influence of FSH.  However, it has been 
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shown that preantral granulosa cells possess FSH receptors.  Further studies confirmed that FSH 
not only promotes granulosa cell proliferation and differentiation, but also decreases the 
proportion of follicles that undergo atresia in vitro [62-64].  For late preantral and antral follicles, 
continued growth is entirely dependent on FSH.  Then, just prior to ovulation, LH or hCG can be 
administered to trigger ovulation.  If given to early, LH and hCG can hinder follicular growth 
and alter the three dimensional structure of the follicle [65]. 
In addition to these effects, gonadotrophins appear to help ease oxidative stress on 
follicles in vitro [66].  In vitro, it is likely that oxidative stress and free radical damage is 
increased due to the incubator air being conditioned to 20% oxygen instead of the approximately 
5% experienced in vivo [53].  This oxidative stress initiates factors within the follicle that 
promotes atresia.  Gonadotrophins seem to lessen these effects by triggering scavenger systems 
within the follicle to maintain viability [66].  However, this damage can be eliminated by 
culturing these follicles at more appropriate oxygen tensions. 
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2.0  SUSPENSION CULTURE 
2.1 INTRODUCTION 
A young female patient undergoing chemo or radiation therapy to treat cancer is often sacrificing 
her fertility and hormonal development, since these treatments can also result in the loss of 
ovarian germ cells, or eggs.  The loss of eggs within the ovary renders a woman sterile, but the 
loss of the follicular unit surrounding the egg results in the inability of the ovary to produce the 
hormone estrogen.  Although it is possible for ovaries to be removed and then frozen prior to 
cancer treatment, there is currently no reliable in vitro technique that can subsequently produce 
fertilizable eggs upon thawing of this stored tissue [6, 67]  
 Eggs, or oocytes, are located in ovarian follicles, the main functional unit of the ovary. 
Once formed, follicles remain dormant in a resting pool until an unknown mechanism activates 
them for growth [6].  Over time follicles are gradually introduced into the growing pool until the 
resting pool is depleted and menopause ensues.  When recruited from the resting pool, follicles 
spend most of their time developing through primordial, primary, and secondary stages [1].  
Prior to puberty, secondary follicles develop up to the antral stage, but then undergo apoptosis. 
After puberty, however, a cohort of follicles is rescued from apoptosis each month by the cyclic 
secretion of pituitary Follicle Stimulating Hormone (FSH) [1].  
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Although much is known about the development of late-stage follicles, relatively little 
has been reported on the development of follicles prior to the antral stage [6, 67].i  In addition to 
the oocyte, which is innermost, a preantral follicle is comprised of epithelial-like granulosa cells, 
which are surrounded by a basement membrane, and theca cells, which are mesenchymal cells 
that surround the exterior side of the basement membrane (Figure 3).  Preantral follicles grow at 
a slow rate and their small size makes them more difficult to isolate for culture [67].  Due to 
complex follicle structure and tightly controlled dynamics of follicle maturation, maintaining 
optimal follicle growth and morphology in vitro is difficult.  Interestingly, follicle flattening and 
rupture [67-70] often occurs around 48 to 72 hours of static culture in a tissue culture well 
(Figure 7).  Follicle rupture is characterized by the disruption of the follicle and the movement of 
the innermost granulosa cells and oocyte through a defect in the basement membrane.  Although 
the granulosa cells can remain healthy after follicle rupture, the normal three-dimensional 
relationship of the follicle has been lost and oocyte maturation may not progress normally.  
 
Figure 7: Flattened and Ruptured Rat Preantral Follicles.  Left: Flattened; Right: Ruptured. 
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 Follicle flattening and rupture could be the result of a non-uniform environment of a flat 
surface, nutrient transfer limitations, or a combination of the two.  In the ovary, follicles are 
spherical and appear uniformly supported since they are located within the ovarian stroma, which 
is rich in extracellular matrix support.  Although there are various approaches to follicle culture 
[53, 67, 70] follicles are conventionally cultured in tissue culture wells.  As a follicle rests on the 
surface of a well, it is possible that the dispersion of forces within the follicle become 
imbalanced, resulting in a loss of architecture and eventually a discrete rupture of the basement 
membrane.  During conventional culture, there is no agitation to prevent a follicle from settling 
to the surface of the well.  Therefore it is also likely that nutrient delivery from the media to the 
follicle is sub-optimal since nutrient diffusion is hindered on the bottom of the follicle, limiting 
the surface area exposed to the nutrient rich media. 
 In the study described herein, we examine the impact of suspension culture systems, 
which provide a more uniform environment to the follicle, on the degree of flattening and 
rupture.  The suspension culture systems used in this study include orbiting test tubes and custom 
designed NASA-type rotating-wall vessels.  The test tubes are positioned in an orbiting device 
that gently agitates the media just enough to prevent a follicle from settling to a surface.  The 
rotating-wall vessels are cylindrical chambers that axially rotate the media, thereby preventing a 
follicle from settling to a surface. 
 Ovarian follicles are extremely fragile, and mechanical damage may be experienced due 
to shearing.  Semipermeable hydrogels have been used to encapsulate tissue, functioning as a 
barrier from infection and mechanical stress [1, 67].  Alginate is one of the most commonly 
applied biomaterials for microencapsulation due to its biocompatibility, high affinity to water, 
and ability to form gels under mild conditions when in the presence of calcium ions [1, 12, 67, 
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69, 70].  Alginate is comprised of chains of alternating blocks of mannuronic acid (M), which 
contributes the elastic property of the gel, and guluronic acid (G), which contributes mechanical 
strength, stability, porosity, and gel forming properties [67, 71].  Alginates are extracted from all 
species of brown algae and contain differing compositions of MM, MG, and GG blocks offering 
a variation in strength and stability [72].  The high porosity range of a 2 % Ca2+ alginate gel 
bead, 5 nm to 200 nm in diameter, only limits the diffusion of large proteins, and thus may be 
beneficial for culturing immobilized whole cells, cell aggregates, or tissue [73]. It has been 
reported that substrates of molecular weight less than 2 x 104, such as glucose, L-tryptophan, and 
α-lactoalbumin, are able to diffuse freely into and from calcium alginate beads at approximately 
the same diffusion rate as in water, [67] while there is some resistance for large proteins of 
molecular weight greater than 3 x 105 [73].  Therefore, follicles imbedded in alginate beads may 
be protected from mechanical shear stress in the suspension culture systems while maintaining 
nutrient delivery and providing three-dimensional structural support.  
 In this study, we evaluate the impact of culturing non-encapsulated and encapsulated rat 
and mouse preantral follicles by the conventional culture system and suspension culture systems 
designed to provide uniform structural support and enhance nutrient delivery.  We investigate 
what role structural support, nutrient delivery, and mechanical shear stress may have on 
follicular growth and morphology.  
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2.2 MATERIALS AND METHODS 
2.2.1 Culture Preparation 
Culture media consisted of α−Minimal Essential Medium (Gibco BRL, Invitrogen Corporation, 
Grand Island, NY) with additives of 8-bromo-cGMP (5 mM), ITS+ (1 % solution of insulin, 10 
mg/L; transferrin, 5.5 mg/L; linoleic acid, 4.7 mg/L; selenium, 5 mg/L), Pen/Strep (1 %, 
penicillin 100 U/ml, streptomycin 100 µg/ml), all from Sigma Chemical Co. (St. Louis, MO), 
and recombinant Follicle Stimulating Hormone, rFSH, (100 ng/ml; Serono Laboratories, 
Geneva).  As a control group, FSH was deleted from the media of some culture wells, since it is 
added to induce follicle growth [1, 67]. Once prepared, culture media was placed into culture 
wells (150 µl/well), test tubes (500 µl/tube), and rotating-wall vessels (4000 µl/vessel) and then 
incubated to maintain conditions of 5 % CO2 and 37 0C.   
Orbital culture was provided by placing the 6 ml culture tubes in a circular rotator plate 
(Glas-Col, Terre Haute, IN), having a diameter of 30.5 cm, which was rotated around its 
horizontal axis at rate between 8-15 rpm.  Therefore, as the plate rotates, the tubes slowly orbit 
the axis of the plate.  Rotational culture was achieved with the use of rotating-wall vessels 
modeled after the NASA design.  These reactors were constructed in house and each cylindrical 
vessel has a diameter of 2.5 cm, a width of 0.6 cm, and a motor that rotates the vessel axially at a 
rate between 8-15 rpm.  
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2.2.2 Ovarian Excision 
Ovaries were excised from euthanized female Sprague-Dawley rats or C56BL/6 mice between 
the ages of 12 to 20 days.  Animals were maintained in a certified animal care facility according 
to approved institutional guidelines.  The ovaries were dissected clean and immediately placed in 
warmed dissection medium consisting of Leibovitz L-15 Medium (Gibco BRL) with 1 % bovine 
serum albumin.   
2.2.3 Follicle Isolation and Culture 
Follicles were mechanically dissected from the ovaries under a dissecting microscope using 25 
gauge needles.  Follicles of 140 µm to 150 µm in diameter were selected and measured using an 
inverted Zeiss microscope equipped with an ocular micrometer.  Follicle diameter was measured 
as the distance between the inner edges of the basement membrane.  Individual follicles were 
then immediately transferred to culture wells, test tubes, or rotating-wall vessels and placed in a 
CO2 incubator for 72 hours.  Follicle diameter was measured daily to evaluate the impact of 
orbital and rotational culture on growth.  For follicles that appeared flattened, the longest 
diameter, a, and the shortest diameter, b, were measured to calculate the degree of flattening, as 
shown in Equation 1. 
Equation 1:  Degree of Flattening = [1 – (a/b)] × 100 % 
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2.2.4 DNA Quantification 
To verify that increased follicle size represented increased follicle cell number, DNA 
quantification was performed on follicles cultured in the orbiting test tubes in the presence and 
absence of FSH.  At 72 hours of culture, DNA was extracted from eight follicles per treatment 
group and was quantified using the fluorescent dye, Hoechst 33258 (bisbenzimidazole; Sigma), 
and a microplate fluorescence reader (Perkin Elmer Life Sciences, Boston, MA) at 365 nm 
excitation and 450 nm emission wavelengths [67].  A range of dilutions of salmon testes DNA 
(Sigma) was used as a standard from which an average content of DNA per follicle (ng/follicle) 
was extrapolated. 
2.2.5 Calcium Alginate Gel Encapsulation 
Prior to being placed in culture, some rat and mouse follicles were encapsulated in calcium 
alginate gel beads in an effort to reduce shear stresses exerted on the follicle itself and to provide 
an environment in which spatial control of follicle-follicle interactions could be analyzed in the 
future.  Once isolated from the ovary 20 to 30 follicles were transferred with glass pipettes to a 
solution of sodium alginate (1-2 % w/v; Sigma) in distilled water.  The mixture of follicles in 
sodium alginate was slowly released through a 25 gauge needle as droplets falling into a beaker 
containing a stirred solution of CaCl2 (0.1 M).  The droplets immediately gelled to form beads.  
A stream of 0.2 µm filtered air was positioned at the tip of the needle to cut the mixture stream 
into small droplets to obtain beads with diameters between 250 µm to 500 µm.  The sodium 
alginate and calcium chloride solutions were each syringe filtered through a 0.2 µm membrane 
and maintained at 37 0C throughout the entire process.   
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Beads containing follicles were then removed from the beaker using glass pipettes and 
immediately transferred to media in a well, tube, or rotating-wall vessel.  The cultures were 
placed in the incubator for a period of 72 hours during which time follicle diameter and 
morphology were examined on a daily basis to determine the impact of encapsulation.  
2.2.6 Statistical Analysis 
Between 25 and 60 follicles were analyzed for each treatment group.  Data points in figures 
represent mean follicle diameter and error bars represent the standard error of the mean. The 
level of statistical significance between mean values was determined by repeated measures 
analysis of variance (ANOVA) followed by Student Newman Keuls or Tukey post-hoc tests.  
Significance between points was accepted at the p<0.05 level. 
2.3 RESULTS AND DISCUSSION 
2.3.1 The Role of FSH on Growth of Preantral Follicles 
Rat preantral follicles were cultured in the presence and absence of Follicle Stimulating 
Hormone (FSH) by the conventional culture system to evaluate the effect of FSH on growth and 
morphology over 72 hours.  Conventionally cultured preantral follicles in the absence of FSH 
(CCS Control) had a slight (2.4 %) but statistically insignificant (p>0.05) increase in diameter 
(Figure 8).  Follicles cultured in the presence of FSH (CCS+FSH) had a 20.5 % (p<0.05) 
increase in average diameter during the culture period.  
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Figure 8: Rat Preantral Follicle Growth. Rat preantral follicles were cultured in the absence of FSH in the 
Conventional Culture System (CCS Control  ) and in the Orbiting Test Tubes – Suspension Culture System (OSCS 
Control  ).  Follicles were also cultured in the presence of FSH in the Conventional Culture System (CCS+FSH ) 
and in the Orbiting Test Tubes – Suspension Culture System (OSCS+FSH  ).  Follicle diameter was measured 
daily using an inverted microscope and approximately 30 follicles were analyzed per treatment group.  Data points 
represent an average diameter ± SEM.  One asterisk, ∗, represents a significant difference (p < 0.05) from both 
control groups, CCS Control and OSCS Control.  Two asterisks, ∗∗, represents a significant difference (p < 0.05) 
also from the CCS+FSH group.               
 
2.3.2 Follicular Flattening and Rupture in the Conventional Culture System 
In these experiments, follicles were analyzed for flattening and rupture to determine if these 
changes are a significant occurrence in the conventional culture system (Figure 9).  
Approximately 53.5 % of the follicles cultured in the CCS+FSH group had an average diameter 
increase of 25 % (p<0.05) but flattened by a degree ranging from 5.1 % to 26 % (average of 14 
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%).  Follicle rupture only occurred in CCS+FSH cultures, between 48 to 72 hours in culture, and 
comprised of 16.3 % of the group.  At the end of the 72 hour culture period, only 30.2 % of the 
follicles in the CCS+FSH group remained spherical. These follicles had a slower rate of growth 
than the other groups of follicles, with an average increase in diameter of 12.5 % (p<0.05).  The 
high rate of disruption in follicle morphology in static culture leads to the conclusion that an 
alternative culture technique is needed to maintain ovarian follicles for long-term developmental 
studies.   
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Figure 9: Rat Preantral Follicle Growth in the Conventional Culture System. Rat preantral follicles were cultured in 
the presence of FSH in the Conventional Culture System.  The diameter growth was measured for follicles that 
appeared to flatten (CCS+FSH flattened  ) and follicles that remained spherical (CCS+FSH spherical  ). Follicle 
diameter was measured daily using an inverted microscope and approximately 30 follicles were analyzed per 
treatment group.  Data points represent an average diameter ± SEM.  An asterisk, ∗, represents a significant 
difference (p < 0.05) from the CCS+FSH spherical group.           
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2.3.3 Follicular Flattening and Rupture in Suspension Culture Systems 
2.3.3.1 Orbiting Test Tube – Suspension Culture System (OSCS) 
 
The mechanism of the flattening and rupturing is not known but is presumably a combination of 
biologic signals that result from the artificial culture environment of the conventional wells.  Our 
goal is to understand which features of the artificial environment contribute significantly to the 
observed morphologic changes.  Static culture wells are likely to experience poor nutrient 
delivery and we therefore explored the impact of gentle agitation on the growth rate and 
morphology of cultured follicles in a slowly orbiting test tube system. 
As shown in Figure 8, rat preantral follicles cultured with FSH in the slowly orbiting test 
tubes (OSCS+FSH) grew to approximately the same size as the follicles cultured in the static 
wells (CCS+FSH) during the first 24 hours.  However, after the 24 hours, the follicles cultured in 
the tubes had an increased growth rate (p<0.05).  Overall, the follicles from this group had a 42 
% increase in average diameter growth by the end of the 72 hour culture, double that obtained in 
the conventional culture system.  Importantly, neither flattening nor rupture of follicles cultured 
in tubes was observed (Figure 13). 
To determine if an increase in diameter corresponded to an increase in cell number, the 
DNA content per follicle was compared for groups of rat follicles cultured in the tubes for 72 
hours in the absence or presence of FSH (Table 3).  The follicles cultured in the presence of FSH 
(OSCS+FSH) contained approximately double the amount of DNA than the follicles cultured in 
the absence of FSH (OSCS Control).  The average diameter of the OSCS+FSH group was also 
approximately double the average diameter of the OSCS Control group, indicating that an 
 39 
increase in diameter indeed corresponds to an increase in cell number for follicles cultured in the 
orbiting test tubes in the presence of FSH.          
Table 3: DNA Quantification.  The percent growth, diameter, and amount of DNA, was measured for eight follicles 
cultured in the absence of FSH (OSCS Control) and eight follicles cultured in the presence of FSH (OSCS+FSH), 
both in the orbiting test tubes.  The values are recorded as averages ± SEM.  An asterisk, *, represents a significant 
difference (p<0.05) from the OSCS Control group. 
  Percent Growth (%) Diameter (µm) Amount of DNA (ng)
OSCS Control 1.7 ± 1.0 144.1 ± 1.4 40.4 ± 8.1 
OSCS+FSH 31.7 ± 2.9* 186.6 ± 4.0* 80.1 ± 9.2* 
 
 
 
 
2.3.3.2 Rotating-Wall Vessel – Suspension Culture System (RSCS) 
 
Although culture in the orbiting test tubes increased the rate of growth, we hypothesized that 
more aggressive mixing of the media could be beneficial.  Rotating-wall vessels have been used 
to culture complex tissues, and one might predict they would be useful for follicle culture.  
However damaging shear stress could be exerted on cells or tissue due to the drag force of the 
rotating media.  The prediction that incubating follicles in a miniature rotating-wall vessel would 
affect their viability was tested experimentally.  Out of fifty-five follicles cultured with FSH for 
72 hours in the rotating-wall vessels 16.4 % did not grow and 74.5 % fragmented, but 
interestingly 9.1 % of the follicles experienced a rapid diameter increase of 29.3 % (Figure 10).  
These follicles had spherical morphology, but the darkened appearance of the granulosa layer 
suggests that the follicles may have experienced some damage. 
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 Figure 10: Rat Preantral Follicles Cultured in the Rotating-wall Vessels. Left: Follicle with darkened granulosa 
cells; Right: Follicle with no apparent damage. 
 
2.3.4 The Impact of Microencapsulation on Follicle Growth and Morphology 
In order to protect follicles from direct shear stress while maintaining the positive aspects of 
suspension culturing, we encapsulated rat, and for comparison, mouse follicles in alginate beads.  
A semipermeable hydrogel, like calcium alginate, allows substrates in the culture media with a 
molecular weight of less than 3 x 105 to easily diffuse through the gel [73].  Alginate is the most 
widely used polymer for cell encapsulation due to its biocompatibility, high porosity, and ability 
to form gel beads that are strong enough to withstand shear forces that typically exist in a 
bioreactor [73].  
Our data show an average increase in diameter of 24.1 % for rat preantral follicles 
(Figure 11) and 29.3 % for mouse preantral follicles (Figure 12), encapsulated in calcium 
alginate beads.  This is less than the increase obtained with non-encapsulated follicles in orbiting 
test tubes, but twice that of follicles in conventional wells.  Unlike the non-encapsulated follicles 
however, neither flattening nor rupture occurred among the encapsulated follicles.  They were 
more spherical and appeared similar to natural morphology, as shown in Figure 13.  Therefore, it 
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is evident from our data that microencapsulating follicles in calcium alginate provides the follicle 
with support and protection from shear stress when cultured in the rotating-wall vessels. 
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Figure 11: Growth of Encapsulated Rat Preantral Follicles.  Rat preantral follicles were encapsulated and cultured 
in the presence of FSH in the Conventional Culture System (CCS+FSH  ), in the Orbiting Test Tubes – Suspension 
Culture System (OSCS+FSH  ), and in the Rotating-wall Vessels – Suspension Culture System (RSCS+FSH  ).  
Follicle diameter was measured daily using an inverted microscope and approximately 20 follicles were analyzed 
per treatment group.  Data points represent an average diameter ± SEM.  
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Figure 12: Growth of Encapsulated Mouse Preantral Follicles.  Mouse preantral follicles were encapsulated and 
cultured in the presence of FSH in the Conventional Culture System (CCS+FSH  ), in the Orbiting Test Tubes – 
Suspension Culture System (OSCS+FSH  ), and in the Rotating-wall Vessels – Suspension Culture System 
(RSCS+FSH  ).  Follicle diameter was measured daily using an inverted microscope and approximately 20 
follicles were analyzed per treatment group.  Data points represent an average diameter ± SEM.  
 
 
 
 
 
 
 43 
 Figure 13: Rat Preantral Follicles.  Rat preantral follicles were cultured for 72 hours in the absence of FSH in (a) 
the conventional culture wells, and in (b) the orbiting test tubes.  Rat preantral follicles were also cultured for 72 
hours in the presence of FSH (c) in the conventional culture wells, (d) in the orbiting test tubes, and calcium alginate 
encapsulated in (e) the rotating-wall vessels.  
 
2.4 CONCLUSIONS 
We investigated features of conventional culture that may contribute to changes in follicular 
morphology.  This study shows that the majority of rat follicles cultured in the conventional 
system loose anatomical integrity by 72 hours of culture.  Although prolonged static culture of 
intact preantral follicles has been successful in mice, [1, 67] similar success with species that 
have larger follicles has not been reported.  For this reason, the mouse model has become a 
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standard for in-vitro maturation of ovarian follicles.  By comparing the growth and morphology 
of mouse follicles grown in different culture systems, the advantages and disadvantages of a 
particular culture technique can more easily be determined.  The rate of follicle development and 
ultimate size varies between species [1] and could be a reason why conventional culture is not as 
successful for larger follicles from species, such as rat, cat, sheep, and human.     
This study is the first to apply a new environment for the culture of rat preantral ovarian 
follicles.  We demonstrated that suspension culture in combination with hydrogel 
microencapsulation maintains follicular growth and morphology more effectively than 
conventional culture in tissue culture wells.  In contrast to static culture, follicles are uniformly 
supported during culture in a rotating-wall vessel, unable to adhere to a surface, and are 
protected from shear stress when embedded in calcium alginate microcapsules.  The cultures in 
this study, however, were short term and therefore studies of long term follicle culture in a 
rotating-wall vessel must be performed to optimize the culture system for follicle maturation.  
Early follicles are avascular but by the time a follicle reaches the antral stage in vivo the theca 
layer has become vascularized with capillaries that continue to expand during follicle growth.  It 
is therefore likely that as a follicle grows the oxygen tension and vessel-wall rotation rate may 
need to be adjusted.  Further study is needed to determine if this technique will be applicable to 
prolonged culture of ovarian follicles and which conditions are most appropriate for optimal 
follicle growth.  
This investigation focused on alterations of follicle architecture that occur in the 
conventional culture system.  We have developed a method that maintains preantral follicular 
morphology during culture.  Follicular maturation is a complex, prolonged, and dynamic process 
that is not yet completely understood.  More investigations of cultured microencapulated follicles 
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in the rotating-wall vessel are necessary to further develop this system to support the entire 
maturation process. 
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3.0  CALCIUM ALGINATE MICROENCAPSULATION OF OVARIAN FOLLICLES 
IMPACTS FSH DELIVERY AND FOLLICLE MORPHOLOGY 
3.1 INTRODUCTION 
The culture of intact ovarian follicles is useful for the study of the regulation of folliculogenesis, 
but may also provide an alternative to ovarian transplant for the preservation of fertility [74]. 
Classically, ovarian follicle culture has been performed in culture dishes, on a flat surface. 
Although ovarian follicles from the mouse can readily be grown on culture plates [52, 75], the 
maturation of follicles from larger mammals has proven to be much more difficult [74]. One 
cause of difficulty may be that larger follicles have different structural needs. Mouse follicles can 
ovulate at 400 µm in diameter [76], whereas rat preovulatory follicles are often greater than 800 
µm in diameter [77]. Though this represents only a doubling of diameter, the volume of the rat 
preovulatory follicle is at least 8 times that of the mouse. The application of standard tissue 
engineering principles to the growth of ovarian follicles in vitro may provide additional tools 
necessary to overcome the structural challenges presented by follicles from larger mammals and 
make significant advances in this field. 
It has been shown that suspension culture both enhances cell proliferation [78] and 
prevents follicle flattening and maintains three-dimensional follicle architecture better than 
culture on flat plates [79]. Though mouse follicles grown in a hanging drop system grew very 
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well compared to follicles grown on flat plates, the follicle diameter was still well under 500 
after 6 days of culture [78]. Rat follicles often rupture at 200 to 250 µm on flat plates. However 
in suspension culture follicles routinely maintain intact survival to about 400 µm. Past this size, 
basement membrane integrity is lost and the three-dimensional structure of the follicle is altered. 
One tissue engineering approach to this problem is to encapsulate the follicles. 
Microencapsulation has been used to provide structural support for a variety of tissues such as 
pancreatic islets [80] and thyroid follicles [81]. 
Alginate is one of the most commonly applied biomaterials for microencapsulation due to 
its biocompatibility, high affinity to water, and ability to form gels under mild conditions when 
in the presence of calcium ions [73, 82-84]. Alginate is comprised of chains of alternating blocks 
of mannuronic acid, which contributes the elastic property of the gel; and guluronic acid, which 
contributes mechanical strength, stability, porosity, and gel forming properties [71, 85]. 
Alginates are extracted from all species of brown algae and contain differing compositions of 
mannuronic acid/mannuronic acid, mannuronic acid/glucoronic acid, and glucoronic 
acid/glucoronic acid blocks offering a variation in strength and stability. Alginate gel beads are 
reported to have a high porosity range and only limit the diffusion of large proteins [72]. It has 
been reported that substrates of molecular weight less than 2 × 104, such as glucose, L-
tryptophan (MW = 204), and α-lactoalbumin (MW = 1.54 × 104), are able to diffuse freely into 
and from calcium alginate beads at approximately the same diffusion rate as in water, while 
larger proteins, such as albumin (MW = 6.9 × 104), could not diffuse freely into the calcium 
alginate beads [86]. Although there is resistance for larger proteins (MW > 2 × 104) diffusing 
into these beads, diffusion from the bead into a surrounding solution devoid of the substrate is 
not hindered until the molecular weight of the substrate approaches 3 × 105 [73]. FSH has a 
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molecular weight of 3 × 104 [87]. Thus, FSH is in the size range where hindrance may play a role 
in FSH availability to follicles encapsulated in calcium alginate beads. 
In this study, the role of a calcium alginate scaffold on follicle growth, survival, and 
morphology in suspension culture was explored. Our previous studies suggested that alginate 
encapsulation slowed follicle growth [79]. Therefore, in these studies we have determined the 
growth rates of follicles in response to different delivery methods of FSH to encapsulated 
follicles. As a result, we have established the ability of calcium alginate to support three-
dimensional follicular growth of intact follicles, but discovered that encapsulation may limit 
follicular access to FSH unless it is included in the alginate bead itself. 
3.2 MATERIALS AND METHODS 
3.2.1 Animals and Ovarian Dissection 
All animal experiments were performed in accordance with National Institutes of Health 
guidelines and with institutional approval. Sprague-Dawley rats were obtained from Hilltop Lab 
Animals (Pittsburgh, PA) and housed under standard conditions. The animals were sacrificed by 
CO2 exposure and cervical dislocation. Ovaries were carefully dissected and placed immediately 
in warmed culture medium, consisting of Leibovitz L-15 Medium (Gibco BRL) with 1% bovine 
serum albumin (Sigma). The follicles were then mechanically dissected from the ovary as 
previously described [69]. All follicles used in the experiments were measured in two 
dimensions, using an inverted microscope fitted with an ocular micrometer. Only intact follicles 
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that were between 150 and 160 microns in diameter were used in culture. There was no statistical 
difference in the starting follicle diameter of any of the groups. 
3.2.2 Calcium Alginate Microencapsulation 
After dissection, 20 to 30 follicles per group were transferred with glass pipettes to a solution of 
sodium alginate (1% w/v; Sigma) in distilled water. (For the groups that required FSH in the 
bead, follicles were transferred to a solution of sodium alginate containing recombinant Follicle 
Stimulating Hormone, rFSH, (Serono Laboratories, Geneva) at a concentration of 1 iu/mL.) The 
mixture of follicles in sodium alginate was slowly released through a 25-gauge needle as droplets 
falling into a beaker containing a stirred solution of CaCl2 (0.1 M). The droplets immediately 
gelled to form beads. A stream of 0.2 µm-filtered air was positioned at the tip of the needle to cut 
the mixture stream into small droplets to obtain beads with diameters between 250 µm to 400 
µm. Beads containing individual follicles (Figure 14) were then removed from the beaker using 
glass pipettes and immediately transferred to media in 12 × 75 mm polypropylene culture tubes. 
Follicles were cultured one per tube. 
 
 
 
 
 
 
 
 50 
 Figure 14: Ovarian Follicle Encapsulated in a Calcium Alginate Bead. Scale bar represents 50 µm. 
3.2.3 Follicle Culture 
Culture media consisted of α-Minimal Essential Medium (Gibco BRL, Invitrogen Corporation, 
Grand Island, NY) with additives of 8-bromo-cGMP (5 mM), ITS+ (1 % solution of insulin, 10 
mg/L; transferrin, 5.5 mg/L; linoleic acid, 4.7 mg/L; selenium, 5 mg/L), Pen/Strep (1 %, 
penicillin 100 U/ml, streptomycin 100 µg/ml), all from Sigma Chemical Co. (St. Louis, MO), 
and recombinant Follicle Stimulating Hormone, rFSH, (1 iu/ml; Serono Laboratories, Geneva). 
In the basal or negative control group, FSH was not included. Culture media was placed into 12 
× 75 mm polypropylene culture test tubes (500 µl/tube) and cultured in 5 % CO2 and 37°C 
humidified incubator. 
Suspension was attained by placing the 12 × 75 mm polypropylene culture tubes in a 
circular rotator plate (Glas-Col, Terre Haute, IN), having a diameter of 30.5 cm, which was 
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rotated around its horizontal axis at rate between 8–15 rpm. Therefore, as the plate rotates, the 
tubes slowly orbit the axis of the plate and the follicle is maintained is fluid suspension. After 72 
hours in culture, follicle diameter was measured once again and follicles were collected for DNA 
quantification and histological analysis. For survival analysis, follicles were observed daily for 
basement membrane integrity and signs of atresia. Atresia is readily apparent as darkening of the 
follicle appearance under the dissecting microscope [64, 79]. Survival analysis cultures were 
continued for 7 days. 
3.2.4 DNA Quantification 
To verify that increased follicle size represented increased follicle cell number, DNA 
quantification was performed on the cultured follicles as previously described [79]. At 72 hours 
of culture, the follicles were released from the beads by allowing the capsules to dissolve in 
sterile PBS (pH 7.4). Follicles (n = 5 for each group) were then trypsinized and DNA was 
extracted from each individual follicle and quantified by using the fluorescent dye, Hoechst 
33258 (bisbenzimidazole; Sigma), and a microplate fluorescence reader (Perkin Elmer Life 
Sciences, Boston, MA) at 365 nm excitation and 450 nm emission wavelengths [88]. A range of 
known dilutions of salmon testes DNA (Sigma) was used to plot a standard curve from which 
follicle DNA content was extrapolated as previously described [79]. This experiment was 
repeated twice with the same result. 
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3.2.5 Histology and Immunohistochemistry 
To confirm that cultured follicles encapsulated in calcium alginate retain normal anatomic 
relationships between the cell types within a follicle, immunohistochemistry for connexin 43 was 
performed on follicles that were cultured in calcium alginate beads with and without FSH. Some 
additional sections were also stained with hematoxylin and eosin. At 72 hours of culture, the 
follicles were released from the beads by allowing the capsules to dissolve in sterile PBS (pH 
7.4). Follicles were embedded in OCT for fluorescent immunostaining. 
Frozen sections were cut at 5 µm and air-dried overnight at room temperature. Sections 
from at least 10 follicles per group were evaluated for connexin staining pattern. After a 10 
minute acetone fixation, slides were again allowed to air dry, and then were rehydrated in PBS 
for 10 minutes. Immunohistochemistry was performed using the M.O.M. immunodetection 
system (Vector Laboratories, Burlingame, Calif.). All reagents were prepared according to kit 
directions and all steps were carried out at room temperature. Slides were incubated with 
blocking reagent for 1 hour. Mouse anticonnexin (Chemicon International, Temecula, CA) was 
prepared in diluent to a final concentration of 0.1 µg/mL and applied to the sections for 1 hour in 
a humidified chamber. For negative control sections, mouse IgG was substituted for the anti-
connexin antibody. After a PBS wash, sections were incubated with biotinylated anti-mouse IgG 
for 10 minutes. Slides were again washed for 10 minutes in PBS, and then incubated with 
fluorescein avidin DCS (1:62.5 in PBS) for 5 minutes. After a final 10 minute PBS wash, slides 
were mounted with Vectashield mounting medium (Vector Laboratories) and digitally imaged 
using a Leica CMR fluorescence microscope. 
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3.2.6 Statistical Analysis 
Statistical analysis for DNA quantification and follicle diameters was performed by analysis of 
variance (ANOVA) with post hoc testing. Survival data was analyzed with the Kaplan Meier 
program contained in the Sigma Stat 3.0 software package (Chicago, Il). Probability values less 
than 0.05 were used to determine significance. 
3.3 RESULTS 
3.3.1 Effect of calcium alginate encapsulation and FSH treatments on follicle diameter 
Average follicle diameters at the beginning and end of the 72-hour culture period are depicted in 
Figure 15. To determine the effects of alginate alone, follicles were encapsulated in calcium 
alginate, but grown in the complete absence of FSH as a negative control. A positive control 
comparison group consisted of follicles grown in the standard fashion and treated with FSH, but 
without encapsulation [79]. As expected, the negative control group of follicles encapsulated and 
grown in the absence of FSH, experienced minimal growth (diameter increase; 6.3%). The 
positive control group of unencapsulated follicles with FSH in the medium experienced a 35.4% 
increase in diameter, consistent with our previous studies [79]. When encapsulated follicles were 
grown in medium containing FSH, a 19.9% increase in follicle diameter over the 72-hour culture 
period was observed (p < 0.05 relative to the negative control). When FSH was included in the 
calcium alginate capsule but not the medium, a 13.5% increase in follicle diameter was observed. 
This was different from the negative control (p < 0.05), but not the previously described FSH in 
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medium group (p > 0.05). However, when follicles were cultured with FSH included in both the 
medium and the bead, a 32.6% increase in follicle size was observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Diameter of follicles cultured under different conditions over 72 h. Each line represents measured 
follicle diameter before and after 72 h of culture (n = 20 – 30 follicles per group). Data points are average diameter 
with standard error bars included for each treatment. Treatment conditions are listed to the right of the data point 
representing average diameter at 72 hours for each group. a, b, c represent statistically different groups (p < 0.05). 
 
 
The size of positive control follicles and encapsulated follicles with FSH placed in the 
medium and the bead were significantly different than the other three treatment groups (Figure 
14, p < 0.05). Furthermore, there was no significant difference between the growth of 
unencapsulated FSH-treated cultures and the encapsulated follicles with FSH present in both the 
bead and the medium (positive control, 54.3 ± 10.1 µm; FSH in bead and media, 49.2 ± 6.8 µm; 
p > 0.05). 
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3.3.2 Survival Analysis 
The effect of encapsulation on follicle survival was evaluated by Kaplan Meier analysis of daily 
observation of cultured follicles. Survival plots for unencapsulated and encapsulated FSH-treated 
follicles are shown in Figure 16. Mean intact survival time for encapsulated follicles, 6 days, was 
greater than the mean intact survival time for unencapsulated follicles, 4.5 days (p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Kaplan Meier Survival Plot. Mean survival time for unencapsulated follicles is 4.5 days while mean 
survival time for encapsulated follicles is 6 days (p < 0.05). 
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3.3.3 DNA Quantification Confirms Follicle Growth 
DNA content of individual follicles was consistent with measured follicle size. The 
unencapsulated follicles in FSH supplemented media (Positive Control) contained 50.7 ± 19.9 ng 
of DNA after 72 hours of culture. The encapsulated follicles with FSH present in the media and 
the bead (Experimental Group) contained 53.9 ± 15.9 ng of DNA, not significantly different 
from the positive control. Both FSH-treated groups contained significantly greater amounts of 
DNA than the encapsulated follicles cultured in the absence of FSH (Negative Control) which 
had only 27.8 ± 11.7 ng of DNA (p < 0.05). 
3.3.4 Connexin 43 Expression in Cultured Follicles 
As seen in Figure 17A, connexin expression (green stain) is very low in follicles in the absence 
of FSH. In the presence of FSH, connexin expression is readily apparent in the unencapsulated 
follicle (Figure 17C). However when the follicle is encapsulated and treated with optimal FSH 
(both in the alginate and in the medium), excellent expression of connexin 43 is seen throughout 
the cross section of the follicle (Figure 17E). This pattern is very similar to the follicle grown in 
vivo (Figure 17G). The negative control pictured (Figure 17H) is a serial section from the same 
follicle from figure 17E and demonstrates that there is minimal background staining in this 
system. Follicle sections stained with H&E are adjacent to the corresponding connexin 
photograph. In the absence of FSH (Figure 17B), the follicle remains intact but the granulosa cell 
layer is poorly organized and contains numerous pyknotic appearing cells. Figure 17D is of an 
FSH treated follicle that was not encapsulated. There is a thickened appearance of the outer 
granulosa cells though the cells around the oocyte appear fairly normal. This is consistent with 
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the area that stains more heavily for connexin. Figure 17F depicts a typical follicle grown in the 
bead with optimal FSH. There is good morphology with a fairly uniform granulosa layer and a 
healthy appearing oocyte. 
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Figure 17: Connexin 43 expression and histology of representative cultured follicles. (A and B) Encapsulated 
follicle in the absence of FSH, (C and D) Unencapsulated follicle grown in FSH supplemented media, (E and F) 
Encapsulated follicle with FSH present in both the media and the bead, (G) Connexin staining in preantral follicle of 
an intact ovary section. (H) Negative control for the immunohistochemical staining, serial section from the same 
follicle as in C. A, C, E, G, H, represent connexin immunohistochemistry. B, D, and F are H&E stained follicle 
sections. In panel C, white line is location of basement membrane. Scale bars represents 50 µm in length. 
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3.4 DISCUSSION 
In this study, we have demonstrated that calcium alginate encapsulation can act as a scaffold to 
support three-dimensional relationships between the cells of a follicle in suspension culture. 
However we have also demonstrated that calcium alginate encapsulation can impede access of 
the follicle to FSH in the medium. 
We have previously shown that FSH is a growth factor for preantral follicles in culture 
[70]. Other investigators have shown that the dosing and timing of follicle exposure to FSH has 
threshold limits for continued growth and survival of mouse follicles [88]. Our previous work 
has demonstrated that encapsulation slowed the rate of follicle growth [79]. There were two 
hypotheses considered to explain the decreased growth response to FSH. Either FSH diffusion 
into the alginate bead was significantly limited, or the bead itself physically hindered the growth 
of the follicle. 
With FSH present only in the bead, a concentration gradient is created between the bead 
and the media. Naturally this gradient would drive the flux of FSH out of the calcium alginate 
capsule. For this case, because the molecular weight is less than 3 × 105, the FSH will freely 
diffuse out of the bead until equilibrium is reached [86]. For a substrate with the molecular 
weight of FSH, equilibrium would be reached within 3 to 5 hours [73], resulting in a much lower 
concentration of FSH within the bead for the bulk of the 72 hour culture. As a result, follicular 
growth response was greatly diminished compared to the positive control (Figure 15). 
Similarly, by adding FSH to only the media, a concentration gradient is established in the 
opposite direction, driving the flux of FSH from the media into the bead. However, due to the 
molecular weight of the hormone being greater than 2 × 104, the diffusion into the capsule will 
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be impeded [73]. The question is then, will the decreased diffusion rate into the calcium alginate 
bead be significant enough to cause the observed reduction in follicular growth (Figure 15). 
To answer this, equal concentrations of FSH were placed in both the bead and the culture 
media. By eliminating the concentration gradients, FSH was not driven from the bead, leaving 
the concentration of FSH within the bead comparable to that present for the positive control. 
Therefore, because the addition of FSH to the alginate bead restored the follicular growth rate to 
that of the positive control, the likely cause of the diminution of follicle growth in our earlier 
studies [79] is a limitation of follicle access to FSH by the encapsulation process. 
In order to confirm appropriate cell-cell interactions within the follicle, we next evaluated 
the expression of the gap junction protein connexin 43 in cultured follicles. Connexin 43 plays a 
key role in follicle development by promoting communication between granulosa cells via the 
exchange of small ions and molecules [89, 90]. Connexin 43 deficient mice have severely 
impaired follicle development beyond the primary stage [91]. The expression and localization of 
connexin 43 is also highly FSH dependant [89]. The evaluation of connexin in our cultured 
follicles provides both a structural and a hormonal assessment of the effect of alginate on follicle 
development and FSH-stimulated differentiation. 
In this study, it was found that the patterned expression of connexin 43 is not affected by 
calcium alginate encapsulation when the FSH is included in both the bead and the medium 
(Figure 17). Encapsulated preantral follicles cultured with FSH, maintain a well developed theca, 
a basement membrane, a normally configured granulosa compartment and a healthy appearing 
egg with a zona pellucida (Figure 17E and 17F). Interestingly, it was observed that the positive 
control lacked the punctuate staining at its periphery (Figure 17C), while the encapsulated 
follicle demonstrated consistent punctuate staining throughout the entire granulosa layer (Figure 
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17E) similar to in vivo preantral follicles (Figure 16G). This may suggest that encapsulating the 
follicle might protect it from possible deleterious shearing forces in the suspension culture 
system, since shear stress has been shown to affect connexin expression [92]. Further studies will 
be needed to more fully evaluate this phenomenon. 
Although a variety of gels and scaffolds exist, calcium alginate has some desired 
advantages. Unlike collagen based gels [93, 94], the follicle can be easily viewed through the 
calcium alginate capsule, allowing for daily observations to be made. Alginate is easily washed 
away with PBS, unlike collagen. The alginate also does not seem to interact with the follicles 
unless ECM or its components are included in the gel [95]. Matrigel has also been used as an 
imbedding medium for follicles. However matrigel is like serum in that it is derived from 
undefined biological sources and can have considerable content variation from lot to lot. In 
contrast, calcium alginate is a well-defined gel and fits with the goal of establishing a completely 
defined culture system that can be stably reproduced and still meet all the nutritional and 
structural needs of the developing follicle. 
3.5 CONCLUSIONS 
These combined findings have demonstrated that microencapsulation can improve the support of 
three dimensional growth of preantral follicles; but requires the inclusion of FSH in the scaffold. 
Further work is necessary to determine if intact follicles can be maintained for longer periods in 
culture with this scaffolding approach. However, care must be taken to determine if the 
scaffolding material itself alters the microfollicular environment. Though follicle development is 
a prolonged and complex process, careful application of tissue engineering principles may 
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facilitate the eventual development of a consistent, standardized in vitro process for follicle 
growth of large mammals that will be reliable enough for gamete production. 
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4.0  DYNAMIC OXYGEN ENHANCES OOCYTE MATURATION IN LONG TERM 
FOLLICLE CULTURE 
4.1 INTRODUCTION 
Primordial follicles have a greater likelihood of surviving this cryopreservation due to their 
smaller size, slow metabolism, and the undifferentiated state of the cells that comprise them [4]. 
Although primordial follicles derived from mice can be grown to maturity using static culture 
techniques under atmospheric oxygen conditions [5-7], to date there has been no successful 
complete in vitro follicle development from larger species, such as rats, pigs and humans [8]. In 
other words, intact rat, primate, or human preantral follicles have not yet been successfully 
cultured to maturation in vitro.  Successful development of a technology in which preserved 
ovarian tissues can be utilized to restore fertility, would be a major development in reproductive 
science.    
Over the past several years, several groups have worked to develop a defined culture 
system for preantral follicular development.  This work has identified a number of factors 
important for follicular growth in vitro.  It has been shown both in vivo and in vitro, that 
preantral follicles respond to FSH treatment with increased cell division, growth and 
differentiation [70].  Other factors that promote growth or differentiation of rat preantral follicles 
in short term culture have been identified (Mullerian Inhibitory Substance [96], Keratinocyte 
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Growth Factor [97], Growth and Differentiation factor 9 [98] and activin [96]). It has also been 
determined that TGF-β induces apoptosis [96], whereas cGMP analogs inhibit apoptosis in 
preantral follicles [70].  While these studies have added to our knowledge of early follicle 
development and greatly improved the media used for in vitro culture of isolated follicles, a 
number of obstacles still remain before follicles can be supported in the proper environment long 
enough to result in normal oocyte maturation. 
We have recently performed studies to determine why rat follicles fail to progress beyond 
the preantral follicle stage in vitro.  Our preliminary studies [79] demonstrated that under 
conventional conditions, rat follicles frequently undergo flattening and rupture with loss of 
anatomic integrity that is important to the normal egg maturation process. When follicles were 
cultured in suspension culture systems, consisting of orbiting test tubes and rotating-wall vessels, 
the follicles did not rupture and exhibited more robust growth. Therefore, we believe that 
advances in bioreactor technologies hold great promise toward the development of a system that 
can support the complex needs of larger follicles that are required for proper development.  In 
the short term, the rat model will allow for more complex studies of follicle development in vitro 
that are unnecessary for the maturation of the smaller mouse follicles.  In the long term it may 
represent the hope for young cancer patients to retain fertility.  More generally, the problems 
associated with nurturing the development of larger follicles mirror many of the unmet 
challenges in tissue engineering as a whole.   
Follicles have traditionally been grown in standard incubators with atmospheric oxygen 
concentrations.  However, primordial and primary follicles exist in the avascular cortex of the 
ovary.  Throughout this region, blood vessels are not observed in close proximity to these 
follicles [11].  The oxygen available to these small follicles would have to diffuse from the 
 65 
peritoneal cavity or nearby large follicles that do have a blood supply.  The partial pressure of 
oxygen in the peritoneal cavity has been measured at 40 mmHg, a far cry from the ~140 mmHg 
obtained in media exposed to normal incubator conditions [99].  Furthermore, the partial 
pressure of oxygen is expected to be even further reduced by crossing the ovarian capsule.  The 
oxygen gradient across the walls of microcapillaries is steep, reducing the intra-capillary levels 
by half [100].  The Po2 across the subrenal capsule drops from the peritoneal level of 40 mmHg 
to 14-19 mmHg [99].  In contrast, an abundance of blood vessels are found in the region of the 
ovary that contains secondary and antral follicles [11].  Differential regulation of follicle 
development in environments reflecting the in vivo Po2 has never been investigated, though it is 
likely that in vivo follicles experience a transition from relative hypoxia in early development to 
the high volume of blood flow and oxygen delivery for pre-ovulatory follicles.  The difficulty in 
achieving in vitro oocyte maturation may be due to the dysregulation of follicle development by 
exposure of early stage follicles to inappropriate oxygen concentrations.   
In this study, we examine the effectiveness of a dynamic oxygen delivery protocol on 
oocyte viability and maturation.  Ovarian follicles were cultured in suspension under two 
different oxygen conditions, a static 20% or a dynamic environment in which the oxygen is 
increased over the duration of the culture period.  Along with an in vivo control group, the 
resulting oocytes are analyzed for survival, germinal vesicle breakdown, and polar body 
extrusion.  Furthermore, additional oocytes derived from these three groups were placed into 
strontium chloride in order to determine the efficiency of parthenogenetic activation.  As a result 
of the activation study, oocytes from the dynamic oxygen group underwent intracytoplasmic 
sperm injection (ICSI) to verify that they were competent to undergo fertilization.    
 66 
4.2 MATERIALS AND METHODS 
4.2.1 Animals and Ovarian Dissection 
All animal experiments were performed in accordance with National Institutes of Health 
guidelines and with institutional approval. Sprague-Dawley rats were obtained from Hilltop Lab 
Animals (Pittsburgh, PA) and housed under standard conditions. The animals were sacrificed by 
CO2 exposure and cervical dislocation.  Ovaries were dissected and placed immediately in 
warmed culture medium, consisting of Leibovitz L-15 Medium (Gibco BRL).  The follicles were 
then mechanically dissected from the ovary using a pair of syringes with 26 gauge needles.  All 
follicles used in the experiments were measured in two dimensions, using an inverted 
microscope fitted with an ocular micrometer. Only intact follicles that were between 140 and 170 
microns in diameter were used in culture. 
4.2.2 Follicle Culture 
Culture media consisted of α-Minimal Essential Medium (Gibco BRL, Invitrogen Corporation, 
Grand Island, NY) with additives of 8-bromo-cGMP (5 mM), ITS+ (1% solution of insulin, 10 
mg/L; transferrin, 5.5 mg/L; linoleic acid, 4.7 mg/L; selenium, 5 mg/L), Pen/Strep (1%, 
penicillin 100 U/ml, streptomycin 100 µg/ml), all from Sigma Chemical Co. (St. Louis, MO), 
and recombinant Follicle Stimulating Hormone, rFSH (0.7 IU/mL), (Serono Laboratories, 
Geneva).  Culture media was placed into 12 x 75 mm polypropylene culture test tubes (500 
µl/tube) and cultured in 5% CO2 and 37 0C humidified incubator.  200 µl of culture media was 
exchanged every 3 days.   
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Suspension culture was attained by placing the 6 ml culture tubes in a circular rotator 
plate (Glas-Col, Terre Haute, IN), having a diameter of 30.5 cm, which was rotated around its 
horizontal axis at rate between 8-15 rpm.  Therefore, as the plate rotates, the tubes slowly orbit 
the axis of the plate. 
4.2.3 Oxygen Protocols 
The incubators used for this study were both CO2 and O2 controlled.  For the ambient oxygen 
group, the oxygen tension was cultured in the traditional static oxygen tension of 20% (Figure 
18).  For the preliminary low oxygen experiment, the oxygen tension was set at 2% (15.2 
mmHg).  For the dynamic oxygen group, the oxygen tension in the incubator was initially set at 
4% (30.4 mmHg), a concentration more similar to what a preantral follicle would experience in 
vivo [99].  In order to mimic the in vivo transition from avascular to vascular oxygen levels, the 
oxygen tension was increased 1% every 24 hours until the end of the 7 day culture period with a 
final oxygen tension of 11% (83.6 mmHg), a level within the normal range for arterial oxygen 
(Figure 18). 
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Figure 18: Dynamic Oxygen Delivery Protocol.  The oxygen tension in the incubator was initially set at 4% (30.4 
mmHg) and increased 1% every 24 hours until the end of the 7 day culture period with a final oxygen tension of 
11% (83.6 mmHg). 
4.2.4 Histology 
The morphology of preantral follicles cultured at different oxygen tensions was analyzed by 
hemotoxylin and eosin staining.  Preantral follicles were cultured in either 15% (115 mmHg) or 
2% (15.2 mmHg) oxygen tension.  After 7 days, the follicles were retrieved from culture and 
fixed in 4% paraformaldehyde.  Follicles were then embedded in Optimal Cutting Temperature 
Compound for sectioning.  Frozen sections were cut at 5 µm and stained with hematoxylin-eosin 
before being imaged using a Leica CMR microscope.  
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4.2.5 Ovulation Induction and Oocyte Maturation 
Follicles were removed from the culture media and placed into media containing α-Minimal 
Essential Medium, Pen/Strep (1%, penicillin 100 U/ml, streptomycin 100 µg/ml), and hCG (1.0 
IU/mL) for 12 hours.  Oocytes were then removed from their surrounding cumulus and placed 
into IVF-30 media (Vitrolife).  Oocytes were initially observed for viability.  Oocytes with 
vacuoles in their cytoplasm or voids in their perivitelline space were considered non-viable.  
After 6 hours in the IVF-30 media, oocytes were examined for germinal vesicle breakdown and 
the presence of an extruded polar body.  Oocyte diameter was measured from inside the zona 
pellucida using SPOT version 3.2.4 software (Diagnostic Instruments).  
4.2.6 Superovulation Protocol 
In order to compare the quality of the oocytes from both culture conditions with an in vivo 
control, immature Sprague-Dawley rats were stimulated to superovulate using pregnant mare’s 
serum gonadotropin (PMSG) subcutaneous injections.  Rats were injected with PMSG (15 IU) at 
10 a.m.  The rats were then injected with human chorionic gonadotropin (30 IU) 48 hours later.  
After 24 hours, the rats were sacrificed and the fallopian tubes dissected to retrieve the ovulated 
oocytes.  The recovered oocytes were placed into the IVF media for 6 hours and examined for 
germinal vesicle breakdown and the presence of an extruded polar body.    
4.2.7 Parthenogenetic Activation 
Follicles were removed from the culture media and placed into media containing α-Minimal 
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Essential Medium, Pen/Strep (1%, penicillin 100 U/ml, streptomycin 100 µg/ml), and hCG (1.0 
IU/mL) for 12 hours.  Oocytes were then removed from their surrounding cumulus and placed 
into IVF-30 media (Vitrolife).  In order to determine oocyte competency, oocytes from the 
dynamic oxygen group, the ambient oxygen group, and the in vivo control group were 
parthenogenically activated by using strontium chloride supplemented IVF-30 media.  Only 
those oocytes that matured through germinal vesicle breakdown were put through the protocol.  
For mammalian oocytes, activation is triggered by intracellular calcium oscillations [101].  These 
calcium oscillations occur as intracellular calcium is released across the egg [102].  This process 
is necessary for the progression of the egg through the cell cycle [103].  Studies on mouse [104] 
and rat [105] oocytes have shown that strontium can provoke the calcium oscillations necessary 
for activation.  However, in the case of strontium-induced parthenogenetic activation, there is no 
consensus on an optimum protocol regarding strontium concentration used and time spent in 
strontium that would result in the most efficient activation rates and the formation of the greatest 
number of blastocysts. 
Strontium chloride (Sigma Chemical Company) was dissolved into IVF-30 medium at a 
concentration of 0.625 mM.  After the 6-hour culture in IVF-30 media, oocytes from the 
dynamic oxygen group were placed into 50 µL drops of strontium supplemented IVF-30 media.  
They were incubated for 8 hours at 370C in 5% CO2 in air.  They were then washed in IVF media 
and cultured for 8 hours in IVF media alone.  Finally, they underwent a second 8 hour culture in 
the strontium supplemented IVF media before being placed back into IVF media for 24 hours.  
Oocytes were then examined for the presence of 2 or more cells.  For all incubation periods, the 
microdrops of IVF media were covered with mineral oil.      
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4.2.8 Oocyte DNA Staining 
Activated oocytes were stained with Hoechst 33342 in order to confirm the presence of a nucleus 
in each cell.  At the end of the activation protocol, oocytes that displayed 2 or more cells were 
placed into a 1 µg/ml working solution of the Hoechst 33342 for 10 minutes followed by two 
PBS washes, 5 minutes.  Oocytes were then digitally imaged using a Leica DM IRB fluorescence 
microscope.  Only those oocytes displaying positive staining in all cells were considered to be 
activated.   
4.2.9 Intracytoplasmic Sperm Injection 
ICSI was performed using a controlled volume microinjection system (Narishige) attached to a 
Leica DM IRB microscope.  Spermatozoa were collected from the cauda epididymidis of a 
mature male Sprague-Dawley rat.  The spermatozoa were suspended in a 10% 
polyvinylpyrrolidone solution (Irvine Scientific).  Spermatozoa were then injected into the 
oocytes in a drop of HTF media supplemented with 10% v/v Synthetic Serum Substitute (Irvine 
Scientific).  After injection, the oocytes were transferred into IVF-medium and incubated at 37oC 
and 5% CO2 in air.  The oocytes used for injections were retrieved from follicles cultured in the 
dynamic oxygen condition and cultured for an additional 6 hours in the IVF media.  Only those 
oocytes that matured through germinal vesicle breakdown were injected.  The injected oocytes 
were observed over the next 24 hours for the presence of 2 pro nuclei and subsequent 
progression to a 2-cell embryo.   
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4.2.10 Statistical Analysis 
The percentages of oocytes that were viable, went through germinal vesicle breakdown, and 
extruded the first polar body were compared between oxygen treatments using the Fisher exact 
probability test.  Significance was accepted at p < 0.05.  
4.3 RESULTS AND DISCUSSION 
Since the overall goal of these studies is to develop a reliable method of attaining mature oocytes 
from in vitro cultured preantral ovarian follicles for the purpose of restoring fertility, the 
parameters used to compare the effects of the dynamic oxygen environment to those of the 
ambient control focused on oocyte viability and oocyte maturation.  Oocyte maturation was 
evaluated by observing the progression of the cultured oocytes through a number of meiotic 
stages.   
Oocytes that are still within a follicle are arrested in the prophase of the first meiotic 
division, the germinal vesicle stage (Figure 19A).  Mature oocytes can spontaneously resume 
meiosis in vitro if they are retrieved from a follicle and separated from the surrounding cumulus 
cells (23).  This induces a process known as germinal vesicle breakdown in which the nucleus 
dissolves in preparation for the completion of meiosis (Figure 19B).  At the conclusion of 
meiosis I, the oocyte will extrude a polar body and enter meiosis II, at which point the oocyte 
will arrest in metaphase II until it is fertilized (Figure 19C).  For the purposes of this study, 
oocytes were observed for germinal vesicle breakdown and the presence of a polar body in order 
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to evaluate the effectiveness of both the ambient oxygen and dynamic oxygen groups at 
producing mature oocytes. 
Figure 20 presents the different outcomes for the cultured oocytes.  The first picture in 
each series (Figures 20A, 20C, 20F, 20I) shows the preantral follicle before it is placed into the 
culture tube.  The second picture in each series (Figures 20B, 20D, 20G, 20J) displays the oocyte 
retrieved from the follicle shown in the first frame.  These oocytes have yet to be cultured in the 
IVF media.  The bottom 3 outcomes have an additional micrograph (Figures 20E, 20H, 20K) 
showing the oocytes after a 6-hour culture in the IVF media.   
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Figure 19: Meiotic stages of the ovulated oocyte and its subsequent progression through either fertilization or 
parthenogenesis. (A) Mature ovulated oocyte. (B) Germinal vesicle breakdown, a process in which the nucleus 
dissolves in preparation for the completion of meiosis occurs. (C) After the first meiotic division, the first polar 
body is extruded.  The oocyte will arrest at this stage until it is fertilized or stimulated to undergo parthenogenesis. 
(D) Fertilization occurs and triggers the second meiotic division. (E) The second polar body is extruded and two pro 
nuclei, one from the ovum and one from the sperm, are present. (F) The two pro nuclei fuse into one nucleus, 
forming a zygote.  (G) Parthenogenesis activation.  (H) Activation triggers a mitotic nuclear division.  (I) This is 
followed by cytokinesis and the formation of a two cell parthenote.    
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Figure 20: Micrographs of Follicles and Subsequent Oocytes.  (A, C, F, I) Follicles on day 0. (B) Non-viable 
oocyte on day 7 from ambient oxygen group. (D, G, J) Viable oocytes on day 7 before culture in IVF-30 media. (E) 
Oocyte after culture in IVF-30 media, no germinal vesicle breakdown from ambient oxygen group. (H) Oocyte after 
culture in IVF-30 media, germinal vesicle breakdown from dynamic oxygen group. (K) Oocyte after culture in IVF-
30 media, germinal vesicle breakdown and extrusion of the first polar body from dynamic oxygen group. 
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4.3.1 In Vivo Control 
The superovulation protocol yielded a total of 19 oocytes that were observed for viability and 
maturation.  Of the 19 oocytes recovered, all 19 were viable.  After culturing the oocytes in the 
IVF medium, 18 (95%) went through germinal vesicle breakdown and extruded the first polar 
body (Figure 21).  The 18 oocytes were then subjected to the parthenogenetic activation protocol.  
Of the 18 oocytes, 15 (83%) were activated (Figure 22). 
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Figure 21: Oocyte Viability and Maturation Data (*: p<0.05). 
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Figure 22: Parthenogenesis Data (*: p<0.05). 
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4.3.2 Ambient Oxygen Culture 
In an attempt to develop a long-term culture system, immature ovarian follicles were cultured for 
7 days in the suspension culture bioreactors under ambient oxygen tension.  Figures 20A and 
20B represents the outcome in which the oocyte has not survived the 7-day culture.  Figure 20B 
is a non-viable oocyte that had retreated from the zona pellucida leaving a sizable portion of the 
perivitelline space empty.  Of the 50 oocytes cultured in the ambient oxygen environment, only 
22 (44%) remained viable.   
The 22 surviving oocytes from the viability study were placed into IVF-30 media to 
determine their efficiency at resuming meiosis.  After 6 hours in the IVF-30 media, germinal 
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vesicle breakdown was observed in 15 of the oocytes.  Figures 20G and 20H portray a viable 
oocyte that went through germinal vesicle breakdown.  The nucleus can clearly be seen in Figure 
20G (arrow), but is no longer present after 6 hours in IVF-30 media (Figure 20H), signifying the 
resumption of meiotic maturation.  This is in contrast to the outcome in Figures 20D and 20E in 
which the oocyte failed to undergo germinal vesicle breakdown as the nucleus is present (arrows) 
both before (Figure 20D) and after (Figure 20E) culture in the IVF-30 media.  Ultimately, the 
ambient oxygen group produced 2 oocytes that extruded the first polar body.  Figures 20J and 
20K show an oocyte that not only went through germinal vesicle breakdown, but also extruded 
the first polar body (arrow). 
From this experiment, it was found that the majority of the oocytes retrieved from the 
ambient oxygen group neither survived the culture nor resumed meiosis.  Compared to the in 
vivo control, there was a significant decrease in all three of the observed parameters, the 
proportion of oocytes that were viable, underwent germinal vesicle breakdown, and extruded the 
first polar body (Figure 21).  Although the yield of mature oocytes was low using this culture 
condition, we wanted to determine if the oocytes generated from the ambient oxygen 
environment could be parthenogenically activated.  With the successful activation of these 
oocytes, we would take a first step toward the derivation of embryonic stem cell lines from in 
vitro matured preantral follicles.      
In addition to being a source of fertilizable oocytes for the restoration of fertility, this 
study also examined whether in vitro matured oocytes could potentially be used to derive 
embryonic stem cell lines through parthenogenetic activation.  Parthenogenesis is a form of 
asexual reproduction in some species in which the oocyte develops without ever being fertilized 
(Figure 19G, 19H, 19I).  A number of methods have been developed to induce the 
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parthenogenetic activation of mammalian eggs.  These eggs will divide mitotically progressing 
to the blastocyst stage, complete with an inner cell mass consisting of embryonic-like stem cells.   
Embryonic stem cell lines have already been derived from the unfertilized oocytes of 
non-human primates [106, 107].  In the case of human eggs, it has been shown that 
parthenogenesis can be induced through several different methods [108, 109].  These activations 
have resulted in the acquisition of pluripotent stem cells from the resulting blastocyst [109].  
Although promising, the primate and human studies have been performed with in vivo matured 
oocytes.  However, it has been found that preantral mouse follicles can be cultured to produce an 
oocyte capable of establishing an embryonic stem cell line from parthenogenesis [5].  In this 
study, the issue of culturing larger follicles from more complex species for the purpose of 
producing oocytes capable of undergoing this activation was addressed. 
In order to assess whether our culture method could produce the mature oocytes 
necessary to attain these stem cells, a number of oocytes from the ambient oxygen group were 
subjected to an activation protocol utilizing the chemical induction agent, strontium.  A total of 
22 oocytes from the ambient oxygen group were put through the parthenogenetic activation 
protocol.  Of the 22 oocytes none were activated.   
Unfortunately, the oocytes from the ambient oxygen group were unable to activate.  It 
was determined that the functional capability of the oocytes cultured at higher oxygen tensions is 
significantly diminished compared to mature oocytes that activate in response to strontium 
exposure [110].  This suggested that the parameters for this culture condition needed to be 
altered in order to develop a successful long-term culture technique that could produce mature 
oocytes with the same potential as those matured in vivo.  We hypothesized that if the oxygen 
tension in the incubator was decreased to in vivo levels for developing preantral follicles, the 
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result would be an increase in the proportion of mature functioning oocytes obtained from the 
culture. 
4.3.3 Low Oxygen Culture 
The preliminary low oxygen experiments focused on the effect that this environment had on the 
morphology of the preantral follicles.  Hemotoxylin and eosin stained sections were compared 
between follicles cultured for 7 days at 2% oxygen tension (Figure 23A and 23B) and 15% 
oxygen tension (Figure 23C and 23D).  The low oxygen sections show that the tissue structure is 
intact and the cells are not necrotic, which is a concern when culturing at such low levels of 
oxygen.  Follicles grown in the high oxygen environment had ruptures in the basement 
membrane, compromising the three dimensional integrity of the tissue along with a loss of cell 
junctions creating empty gaps around the oocyte.  From these observations, it was found that not 
only could preantral follicles survive in a low oxygen environment, but also their three 
dimensional structure more closely resembled in situ follicle structure.  However, a static low 
oxygen tension is also not what developing follicles experience in vivo.  We further hypothesized 
that for long-term cultures designed to support follicle maturation, a method of oxygen delivery 
that would increase over the duration of the culture period should be implemented. 
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Figure 23: Hemotoxylin and eosin stained sections of follicles cultured for 7 days in (A, B) low oxygen tension 
(2%) or (C, D) high oxygen tension (15%).  
4.3.4 Dynamic Oxygen Culture 
Utilizing in vivo oxygen tensions to enhance tissue function during in vitro culture has been used 
in a number of related fields.  It has been shown that maturing porcine oocytes in a low oxygen 
environment improves not only their ability to parthenogenetically activate but also the quality of 
the resulting blastocysts [111].  It was also determined that culturing embryos at an oxygen 
tension characteristic of levels found in the oviduct and uterus improved both the establishment 
and maintenance of murine stem cells [112].  It is becoming evident that the fields of follicular 
development, oocyte maturation, and embryo culture are benefiting from this trend to mimic the 
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unique in vivo metabolic needs of these avascular tissues.  In this spirit, several groups have 
examined the effects of lower oxygen tensions on follicle growth and development [113-115].  It 
was found that by culturing preantral follicles under 5% oxygen, there was a significant increase 
in oocyte survival [113, 115].  Although these studies use oxygen tensions that are more suitable 
for early follicle development, the oxygen concentrations are still held constant for the duration 
of the culture periods.  To better mimic the native oxygen environment, the oxygen 
concentrations for the dynamic oxygen protocol implemented in this study were based on the 
unique in vivo realities experienced by maturing follicles throughout their life-cycle in the ovary.   
For the purposes of our study, this dynamic oxygen protocol was then combined with the 
use of bioreactors that enable follicles to grow without flattening [79].  As in the ambient oxygen 
culture, immature follicles were cultured for 7 days at which point the oocytes were retrieved and 
observed for viability, germinal vesicle breakdown, and polar body extrusion.  Of the 54 oocytes 
cultured in the dynamic oxygen environment, 35 (65%) were viable.  After 6 hours in the IVF-30 
media, germinal vesicle breakdown was observed in 30 (56%) oocytes from the dynamic oxygen 
group, with 8 of those oocytes extruding the first polar body. 
Although these figures are still significantly less than the in vivo control values, 
significant increases were observed in the dynamic oxygen group for both the proportion of 
oocytes that remained viable and the proportion of oocytes that resumed meiosis compared to the 
ambient oxygen group (Figure 21).  The dynamic oxygen environment not only permitted the 
development of mature oocytes, but significantly increased the number of oocytes that resumed 
meiosis by undergoing germinal vesicle breakdown, showing that both the quantity and quality 
of the oocytes were enhanced using this culture method.  Furthermore, it was determined that 
there was no significant difference (p>0.05) in oocyte diameter between the in vivo control, 
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70.4+/-5.6 µm, the dynamic oxygen, 68.5+/-2.5 µm, and the ambient oxygen, 68.8+/-2.7 µm 
groups.  We next wanted to determine if the oocytes generated from the dynamic oxygen 
environment could be parthenogenically activated.   
Utilizing the chemical inducing agent strontium, a total of 28 oocytes from the dynamic 
oxygen group were put through the parthenogenetic activation protocol.  Of the 28 oocytes 
cultured in the dynamic oxygen environment, 7 were successfully activated.  This is a significant 
increase when compared to the ambient oxygen group that failed to produce a single oocyte 
capable of activation (Figure 22).  Figure 24 shows the micrograph of an activated oocyte and its 
corresponding Hoechst-stained image.  Figure 24A shows the activated oocyte at the 2-cell stage 
while Figure 24B is the fluorescent image of the oocyte with the nuclear-staining Hoechst dye 
confirming the presence of a nucleus in each of the 2 cells.  
 
 
 
 
         
 
 
 
 
Figure 24: (A) Micrograph of Activated Oocyte (400x) (B) Hoechst-stained Activated Oocyte (400x). 
 
The derivation of embryonic stem cells from these parthenotes is beyond the scope of this 
paper.  However, by activating these eggs, we confirmed that the oocytes retrieved from this 
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improved culture environment have the potential to become a source for embryonic stem cells.  
Furthermore, this indicates that culturing preantral follicles in a high oxygen environment will 
limit the functional potential of the oocytes. 
4.3.5 Intracytoplasmic Sperm Injection 
From the oocyte viability and maturation studies, it was found that the long-term culture of 
preantral ovarian follicles for the purpose of producing mature oocytes can become more 
efficient by altering the oxygen environment to mimic the native ovarian environment.  
However, in order to prove that this culture technique can ultimately be utilized as a method to 
restore fertility, the fertilization of a cultured oocyte must be demonstrated.  
In this study, 8 oocytes from the dynamic oxygen group were injected with sperm from a 
mature male Sprague-Dawley rat.  Of these 8 oocytes, 2 pro nuclei (2pn) were observed in 2 of 
the oocytes within 24 hours.  Figure 25A shows one of the 2pn oocytes while Figure 25B is the 
fluorescent image of the oocyte with the nuclear-staining Hoechst dye confirming the presence 
of both pro nuclei in the egg.  Neither of these eggs progressed to the 2-cell stage (Figure 19F), 
however, the presence of both pro nuclei in the egg confirm the fertilization (Figure 19E). 
By fertilizing these oocytes, it gives us the proof of concept that this dynamic oxygen 
culture technique is a potential option to restore fertility in females who undergo sterilizing 
therapy.  As this project moves forward, we will look to improve the ICSI procedure and the 
media used to culture the embryos in order to support the embryo to later stages of development.     
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Figure 25: (A) Micrograph of Fertilized Oocyte (400x).  Arrows indicated the 2 pro nuclei. (B) Hoechst-stained 
Fertilized Oocyte (400x). 
 
4.4 CONCLUSIONS 
The dynamic oxygen environment produced a significantly higher yield of healthy oocytes than 
the static control.  More importantly, the oocytes from the dynamic oxygen environment were 
significantly more efficient at progressing through germinal vesicle breakdown than their 
compliments in the control.  In conclusion, these data demonstrate that both the yield and quality 
of the oocytes derived from in vitro cultured preantral follicles can be improved by utilizing a 
dynamic oxygen protocol designed to mimic the in vivo environment of the ovary.  Furthermore, 
it was found that not only can immature rat preantral follicles be cultured to produce oocytes 
capable of parthenogenetic activation, but the activation was only achieved when the oocyte had 
been cultured in the dynamic oxygen environment.  Finally, the ex vivo ovulated oocytes can be 
fertilized by ICSI and if we are able to demonstrate a similar approach with human follicles, then 
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dynamic oxygen culturing would provide hope to young children who must sacrifice fertility for 
life.  
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5.0  THE EFFECT OF OXYGEN CONCENTRATION ON PREANTRAL FOLLICLE 
GENE EXPRESSION 
5.1 INTRODUCTION 
In our previous study (Chapter 4), it was found that the utilization of a dynamic oxygen protocol 
during the culture of preantral follicles significantly increased the proportion of follicles that 
remained viable, resumed meiosis, and parthenogenetically activated compared to those follicles 
cultured at the standard ambient oxygen pressure of 20% (152 mmHg).  The dynamic oxygen 
protocol was modeled after the in vivo oxygen environment of the native ovary, beginning with 
the initial oxygen tension in the incubator set at 4% (30.4 mmHg).  In order to mimic the in vivo 
transition from avascular to vascular oxygen levels, the oxygen tension was increased 1% every 
24 hours until the end of the 7 day culture period with a final oxygen tension of 11% (83.6 
mmHg), a level within the normal range for arterial oxygen.   
We believe that the positive results observed from the dynamic oxygen group are 
attributed to an environment that better mimicked that experienced by preantral follicles in the 
native ovary.  In contrast, we feel that the damaging effect the high oxygen environment had on 
the ambient oxygen group is due to the drastic increase the preantral follicles experienced at the 
onset of the culture.  By being placed in an environment more suitable to mature graafian 
follicles [99], the granulosa cells may not differentiate properly, leading to desynchronized 
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follicle development.  Previous to this study, no group has analyzed global gene expression 
patterns of preantral follicles cultured in varied oxygen environments and compared them to the 
gene expression patterns of native preantral follicles   
In this study, gene chip analysis was performed on three groups of follicles, an in vivo 
control, a three-day high oxygen group, and a three-day low oxygen group.  The objective was to 
compare gene expression of the in vivo control group to both the low and high oxygen culture 
groups.  Within this analysis, the desire was to determine which experimental groups’ gene 
expression profile was more similar to that of the control and  which genes and pathways were 
altered for each of the experimental groups as they pertain to the control.  
5.2 MATERIALS AND METHODS 
5.2.1 Animals and Ovarian Dissection 
All animal experiments were performed in accordance with National Institutes of Health 
guidelines and with institutional approval. Sprague-Dawley rats were obtained from Hilltop Lab 
Animals (Pittsburgh, PA) and housed under standard conditions. The animals were sacrificed by 
CO2 exposure and cervical dislocation.  Ovaries were dissected and placed immediately in 
warmed culture medium, consisting of Leibovitz L-15 Medium (Gibco BRL).  The follicles were 
then mechanically dissected from the ovary using a pair of syringes with 26 gauge needles.  All 
follicles used in the experiments were measured in two dimensions, using an inverted 
microscope fitted with an ocular micrometer. Only intact follicles that were between 140 and 170 
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microns in diameter were used in culture.  Intact follicles between 200 and 250 microns in 
diameter were used as the in vivo control group. 
5.2.2 Follicle Culture 
Culture media consisted of α-Minimal Essential Medium (Gibco BRL, Invitrogen Corporation, 
Grand Island, NY) with additives of 8-bromo-cGMP (5 mM), ITS+ (1% solution of insulin, 10 
mg/L; transferrin, 5.5 mg/L; linoleic acid, 4.7 mg/L; selenium, 5 mg/L), Pen/Strep (1%, 
penicillin 100 U/ml, streptomycin 100 µg/ml), all from Sigma Chemical Co. (St. Louis, MO), 
and recombinant Follicle Stimulating Hormone, rFSH (0.7 IU/mL), (Serono Laboratories, 
Geneva).  Culture media was placed into 12 x 75 mm polypropylene culture test tubes (500 
µl/tube) and cultured in 5% CO2 and 37 0C humidified incubator.   
Suspension culture was attained by placing the 6 ml culture tubes in a circular rotator 
plate (Glas-Col, Terre Haute, IN), having a diameter of 30.5 cm, which was rotated around its 
horizontal axis at rate between 8-15 rpm.  Therefore, as the plate rotates, the tubes slowly orbit 
the axis of the plate. 
 The incubators used for this study were both CO2 and O2 controlled.  For the ambient 
oxygen group, the oxygen tension was cultured in the traditional static oxygen tension of 20%.  
For the low oxygen group, the oxygen tension was set at 4%.  Both groups were cultured for 
three days.  The third group in this study was the control group comprised of in vivo follicles.  
These follicles were excised from the ovary with diameters between 200 and 250 microns.  
Instead of being placed into culture, this group immediately went through the RNA isolation 
protocol. 
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5.2.3 RNA Isolation 
Follicles of the same sample group were placed into 1mL of Trizol reagent, passing the lysate 
several times through a pipette.  The lysate was then incubated for 5 minutes at 30oC and 
transferred to an RNase-free tube.  0.2 mL chloroform and 10ug glycogen were then added to the 
trizol reagent, shaken vigorously for 15 s, and incubated at room temperature for 3 minutes.  
Next, the reagent was centrifuged at 11,000 rpm for 15 minutes at 2oC.  The upper phase of the 
resulting solution was transferred into a fresh tube and mixed with 250 uL of isopropyl alcohol.  
This was again incubated for 10 minutes at 30oC and centrifuged for an additional 10 minutes at 
11,000 rpm.  The RNA pellet was then washed with 75% ethanol and centrifuged at 7500 rpm 
for 5 minutes before being air dried for 10 minutes.  Finally, the RNA pellet was redissolved in 
20 uL of diethyl pyrocarbonate treated water and incubated at 59oC for 10 minutes. 
5.2.4 RNA Quality 
Verifying the integrity of the RNA starting material is crucial for proper gene expression 
analysis.  In this study, each sample was tested using the Agilent 2100 bioanalyzer.  The 
bioanalyzer uses electrophoretic separation to separate the RNA sample and then detect it using 
laser induced fluorescence detection.  The software then creates an electropherogram that 
provides a visual assessment of the quality of the RNA sample along with the ratio of the 18S 
and 28S ribosomal subunits.   
 In order to more accurately interpret these electropherograms, the RNA Integrity Number 
(RIN) was developed [116].  The RIN software algorithm ranks RNA on a scale from 1 to 10, 1 
being most degraded and 10 being intact (Figure 26).   
 91 
 
Figure 26: Sample electropherograms used to train the RNA Integrity Number (RIN) software. Samples range from 
intact (RIN 10), to degraded (RIN 2). Reprinted from [116] 
 
 Ideally, the electropherogram will have a low baseline absent of any signal with sharp 
ribosomal peaks.  This algorithm analyzes the important areas of the entire electropherogram for 
proper signal areas, intensities, and ratios.  These areas include the pre-, 5S-, fast-, inter-, 
precursor-, and post regions along with the marker, 18S, and 28S peaks (Figure 27).  For the 
RNA to be considered to have the appropriate integrity for gene expression analysis, the 
minimum desirable RIN is 6.0. 
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Figure 27: Electropherogram detailing the regions that are indicative of RNA quality. Reprinted from [116] 
5.2.5 RNA Amplification 
RNA samples were prepared using the Illumina® Totalprep RNA Amplification Kit from 
Ambion according to manufacturer’s instructions [117].  Briefly, 500 ng total RNA was used to 
prepare ds-cDNA using T7-oligo(d)T primer.  Reverse transcription was followed by in vitro 
transcription in the presence of biotinylated nucleotides (Figure 28).   
Biotinylated cRNA samples were hybridized to RatRef-12 Expression Beadchip arrays in 
a proprietary hybridization buffer overnight at 58°C on a platform rocker.  Following the 18 hour 
hybridization, arrays were washed in proprietary buffers to remove excess labeled cRNA. 
Florescent tagging was achieved by incubation with Cy3-streptavidin for 10 min at RT.  Excess 
dye solution was removed with further buffer washes.  Slides were dried by low speed 
centrifugation and scanned in the Illumina BeadScanner.  Resulting image files were analyzed 
using Bead Studio version 3.2.3. 
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Figure 28: RNA Amplification Procedure. Reprinted from [117] 
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5.2.6 Experimental Design 
The study design for analyzing the samples is depicted in Figure 29.  For the in vivo control, high 
oxygen and low oxygen groups, the expression value for each gene is the average gene 
expression value from three separate samples analyzed on three different microarrays. 
 
Figure 29: Data Sample Design. 
 
5.2.7 Normalization 
When processing RNA for gene chip analysis, systematic variations between samples can occur, 
resulting in errors that hinder proper expression value comparison.  These variations are due to 
factors such as concentration differences in a processing solution or inconsistent hybridization 
temperatures [118].  In order to improve the validity of the data and ensure that variations in 
gene expression levels are biological in nature, normalization methods that factor out these 
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systemic errors have been developed.  In this study, the gene expression values were normalized 
using four different normalization algorithms: average, rank invariant, cubic spline, and quantile. 
 The average method regulates the intensities of two samples of gene array values such 
that their means become equal [118].  This is a simple algorithm that determines a normalization 
factor by dividing the mean of sample A with the mean of sample B and then scaling all the gene 
expression values in the sample with the lower mean by the determined factor. 
 The rank invariant method determines the scaling factor by only dividing the average of 
rank invariant genes instead of every gene.  These rank invariant genes are genes that have 
expression values that appear in a regular order compared to other genes within the sample [118].  
By using this method, outliers are not used to determine the scaling factor.  The underlying 
assumption of this method is that there exists a subpopulation of genes in the samples being 
compared that will not be differentially expressed [118].  Therefore, samples from different 
tissues most likely could not be normalized using this method. 
 The cubic spline algorithm is non-linear.  With this method, the array data is divided into 
a group of quantiles.  Then the average for each quantile in sample A is divided by the average of 
the corresponding quantile in sample B, resulting in a different scaling factor for each quantile 
[118].  Each of these factors is then used to scale only the genes within that specific quantile. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Global Gene Expression Analysis 
The initial gene expression analysis focused on the entire gene expression patterns for each 
group.  Correlation plots comparing gene expression intensities between both the low and high 
oxygen groups vs. the in vivo control were analyzed for each normalization method, none (Figure 
30A and 30B), average (Figure 31A and 31B), cubic spline (Figure 32A and 32B), rank invariant 
(Figure 33A and 33B), and quantile (Figure 34A and 34B).  From these plots, R2 values were 
obtained and compared to determine if either culture condition caused the preantral follicles to 
produce an overall gene expression pattern that more closely resembled the gene expression 
pattern from the in vivo control (Table 4). 
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Figure 30: Global gene expression correlation plot (No normalization). (A) low oxygen group vs. in vivo control 
group  (B) high oxygen group vs. in vivo control group. 
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Figure 31: Global gene expression correlation plot (Average normalization method). (A) low oxygen group vs. in 
vivo control group  (B) high oxygen group vs. in vivo control group.  
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Figure 32: Global gene expression correlation plot (Cubic Spline normalization method). (A) low oxygen group vs. 
in vivo control group  (B) high oxygen group vs. in vivo control group.  
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Figure 33: Global gene expression correlation plot (Rank Invariant normalization method). (A) low oxygen group 
vs. in vivo control group  (B) high oxygen group vs. in vivo control group.  
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Figure 34: Global gene expression correlation plot (Quantile normalization method). (A) low oxygen group vs. in 
vivo control group  (B) high oxygen group vs. in vivo control group.  
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Table 4: Summary of R2 Values from the Normalization Methods. 
 
0.89540.9073Quantile
0.88690.9044Rank Invariant
0.89440.9070Cubic Spline
0.88680.9044Average
0.88680.9046No Normal
High Oxygen Group 
VS. 
in vivo Control
Low Oxygen Group 
VS.
in vivo Control
R2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the RatRef-12 expression beadchip containing over 22,000 probes designed to 
analyze the entire rat genome, a drastic difference between the low oxygen group and high 
oxygen group was not expected.  However, from the R2 values shown in table 4, the low oxygen 
group displays a better correlation to the in vivo control than the high oxygen group.  Although 
the difference is small, it is consistent, remaining robust to several different normalization 
methods.  For this reason, it is believed that this difference is due to biological variations within 
the cultured follicles rather than any systematic error in the processing of the samples [118].   
5.3.2 Differentially Expressed Genes 
Significant differences in R2 values for whole genome correlation plots would most likely be 
observed in comparisons between different tissue types.  When analyzing differences between 
samples of the same tissue, such as in this study, the differentially expressed genes are identified 
and then investigated in order to isolate subsets of genes that would affect proper tissue function.  
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Algorithms that can identify pathway differences for certain processes and disease states have 
been developed.  However, both the low oxygen group and the high oxygen group in this study 
were expected to be relatively healthy, making the differences between the sample groups more 
subtle.   
For the purpose of this study, data mining was performed to uncover the genes that were 
differentially expressed between the low oxygen group and the in vivo control (Table 5 and 
Figure 35) and between the high oxygen group and the in vivo control (Table 6 and Figure 36).  
These genetic variations were then analyzed to determine if any could have an adverse affect on 
preantral follicle development.   
Follicular development during the preantral stage is controlled by several crucial 
processes within the follicle: the production of the proper differentiation and growth factors [96, 
97] and the maintenance of appropriate levels of steroidogenesis and metabolism [119-121].  
These processes synergistically regulate the growth and maturation of both the oocyte and the 
cells that support it [122].   
Oocyte growth and maturation is controlled by nutrients and molecular signals 
originating from the surrounding granulosa cells [122].  Granulosa cells differentiate throughout 
the life of a follicle, producing and transporting different growth and maturation factors to the 
oocyte during the different stages of development.  The rate at which these cells differentiate and 
the stage-dependent manner with which they secrete the appropriate factors ensure proper 
development.  It is this interaction between the granulosa cells and the oocyte that may be the 
most crucial process to maintain throughout any long-term culture system [122].  Studies have 
shown that growth factors such as growth differentiation factor-9 not only initiate granulosa cell 
proliferation, but also regulate granulosa cell differentiation[122].  Therefore, in order to design a 
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culture system that properly supports oocyte growth and maturation, normal proliferation and 
differentiation of the granulosa cells must be maintained. 
 
Table 5: Differentially expressed genes in the low oxygen group vs. the in vivo control 
  
51.790PREDICTED: Rattus norvegicus similar to macrophage migration inhibitory factor (LOC500271), mRNA.31
55.129PREDICTED: Rattus norvegicus 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), mRNA.30
55.358PREDICTED: Rattus norvegicus similar to FAD104 (predicted) (LOC294925), mRNA.29
-57.533Rattus norvegicus connective tissue growth factor (Ctgf), mRNA.28
59.309Rattus norvegicus macrophage migration inhibitory factor (Mif), mRNA.27
61.285PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC500506), mRNA.26
61.568PREDICTED: Rattus norvegicus similar to Tpi1 protein (LOC498731), mRNA.25
65.114Rattus norvegicus BCL2/adenovirus E1B 19 kDa-interacting protein 3 (Bnip3), mRNA.24
-66.584Rattus norvegicus cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA.23
66.845Rattus norvegicus glucose phosphate isomerase (Gpi), mRNA.22
67.001Rattus norvegicus aldolase A (Aldoa), mRNA.21
68.187PREDICTED: Rattus norvegicus triosephosphate isomerase 1 (Tpi1), mRNA.20
69.463Rattus norvegicus cellular retinoic acid binding protein 2 (Crabp2), mRNA.19
69.775Rattus norvegicus hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA.18
70.109PREDICTED: Rattus norvegicus similar to triosephosphate isomerase (LOC500959), mRNA.17
70.262PREDICTED: Rattus norvegicus glyceraldehyde-3-phosphate dehydrogenase (Gapd), mRNA.16
-72.180Rattus norvegicus beta-glo (MGC72973), mRNA.15
73.989PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)  (EC 1.2.1.12) -
mouse (LOC502770), mRNA.
14
75.782Rattus norvegicus monocarboxylate transporter (Slc16a3), mRNA.13
81.340PREDICTED: Rattus norvegicus similar to L-lactate dehydrogenase A chain (LDH-A) (LDH muscle subunit) (LDH-M) 
(LOC307731), mRNA.
12
81.478PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC498099), mRNA.11
81.792PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC498618), mRNA.10
86.707PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC498881), mRNA.9
88.022PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC499433), mRNA.8
88.077Rattus norvegicus phosphoglycerate kinase 1 (Pgk1), mRNA.7
88.445PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC364848), mRNA.6
95.755PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC290634), mRNA.5
96.607Rattus norvegicus lactate dehydrogenase A (Ldha), mRNA.4
100.867PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC295452), mRNA.3
-114.528Rattus norvegicus hemoglobin beta chain complex (Hbb), mRNA.2
-117.092Rattus norvegicus hemoglobin alpha, adult chain 1 (Hba-a1), mRNA.1
J5 scoreGeneRank
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Figure 35: Expression pattern grid for low oxygen group vs. in vivo control.  
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Table 6: Differentially expressed genes in the high oxygen group vs. the in vivo control 
  
39.533PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC498881), mRNA.28
-39.610Rattus norvegicus seminal vesicle secretion 5 (Svs5), mRNA.27
40.957PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC499433), mRNA.26
40.961Rattus norvegicus 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr), mRNA.25
41.028PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC364848), mRNA.24
-41.078Rattus norvegicus LR8 protein (Lr8), mRNA.23
43.149Rattus norvegicus fucosidase, alpha-L- 1, tissue (Fuca), mRNA.22
-44.346Rattus norvegicus lumican (Lum), mRNA.21
-44.628Rattus norvegicus ribosomal protein S9 (Rps9), mRNA.20
45.900PREDICTED: Rattus norvegicus similar to glyceraldehyde-3-phosphate dehydrogenase (LOC498099), mRNA.19
-49.181Rattus norvegicus apolipoprotein E (Apoe), mRNA.18
-49.377PREDICTED: Rattus norvegicus procollagen, type VI, alpha 3 (predicted) (Col6a3_predicted), mRNA.17
-49.395PREDICTED: Rattus norvegicus similar to ribosomal protein S19 (LOC314733), mRNA.16
-49.927Rattus norvegicus decorin (Dcn), mRNA.15
50.305PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC290634), mRNA.14
-50.872PREDICTED: Rattus norvegicus insulin-like growth factor binding protein 7 (predicted) (Igfbp7_predicted), mRNA.13
51.390Rattus norvegicus similar to acetyl CoA transferase-like (MGC95138), mRNA.12
52.366PREDICTED: Rattus norvegicus similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (LOC295452), mRNA.11
53.114Rattus norvegicus lactate dehydrogenase A (Ldha), mRNA.10
-55.800Rattus norvegicus connective tissue growth factor (Ctgf), mRNA.9
-57.056Rattus norvegicus beta-glo (MGC72973), mRNA.8
58.792PREDICTED: Rattus norvegicus 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), mRNA.7
64.659Rattus norvegicus cellular retinoic acid binding protein 2 (Crabp2), mRNA.6
-65.208Rattus norvegicus procollagen, type I, alpha 2 (Col1a2), mRNA.5
-65.381Rattus norvegicus matrix Gla protein (Mgp), mRNA.4
-65.982Rattus norvegicus cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA.3
-89.366Rattus norvegicus hemoglobin beta chain complex (Hbb), mRNA.2
-92.132Rattus norvegicus hemoglobin alpha, adult chain 1 (Hba-a1), mRNA.1
J5 scoreGeneRank
36.764Rattus norvegicus hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA.36
-36.833PREDICTED: Rattus norvegicus similar to 40S ribosomal protein S19 (LOC363531), mRNA.35
36.889Rattus norvegicus follistatin (Fst), mRNA.34
37.016PREDICTED: Rattus norvegicus glyceraldehyde-3-phosphate dehydrogenase (Gapd), mRNA.33
-37.352PREDICTED: Rattus norvegicus similar to 40S ribosomal protein S9 (LOC367102), mRNA.32
38.514Rattus norvegicus phosphoglycerate kinase 1 (Pgk1), mRNA.31
38.778PREDICTED: Rattus norvegicus similar to L-lactate dehydrogenase A chain (LDH-A) (LDH muscle subunit) (LDH-M) (LOC307731), mRNA.30
39.293Rattus norvegicus similar to myo-inositol 1-phosphate synthase A1, mRNA (cDNA clone MGC:93930 IMAGE:7113337), complete29
J5 scoreGeneRank
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Figure 36: Expression pattern grid for high oxygen group vs. in vivo control. 
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5.3.2.1 Differentiation and Growth 
In analyzing the sets differentially expressed genes (Table 5 and 6), it was uncovered that 
both the high oxygen group and low oxygen group differentially express a gene when compared 
to the in vivo control that plays a role in granulosa cell proliferation and differentiation.  In both 
high and low oxygen groups, connective tissue growth factor is downregulated.  During preantral 
follicle development, this gene is abundantly expressed in rat granulosa cells[119].  Due to the 
expression patterns of connective tissue growth factor throughout follicular development in the 
rat, it was found to play a role in follicle growth and thecal cell recruitment [119].  However, in 
vitro, connective tissue growth factor has been found to be downregulated when cultured with 
FSH [119].  For this reason, this particular growth factor showed similar expression levels in 
both the high and low oxygen groups, but instead is altered due to the presence of FSH in both 
culture groups. 
Although connective tissue growth factor remained the only growth and differentiation 
factor differentially expressed in the low oxygen group, it was discovered that the high oxygen 
group differentially expressed two additional genes that help regulate this process, follistatin, and 
decorin.  
Follistatin was found to bind activin, reducing activin activity [123].  Activin is produced 
by the granulosa cells and, in an autocrine fashion, regulates the differentiation of granulosa cells 
[123, 124].  In the case of the undifferentiated granulosa cells present in preantral follicles, 
activin induces FSH receptors, allowing for the follicles to become responsive to FSH.  FSH, in 
turn, stimulates the production of additional activin and activin receptors in the granulosa cells to 
further increase FSH receptor expression.  It is believed that along with this effect on FSH 
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receptors, activin promotes estradiol production, leading to not only the differentiation of the 
granulosa cells, but also the prevention of luteinization and atresia [123].   
Follistatin has been shown to have the opposite effect in vitro.  It inhibits the effects of 
activin, leading to the premature luteinization of the preantral follicle or atresia [123].  In this 
study, follistatin was found to have been upregulated in the high oxygen group compared to the 
control, but not differentially expressed in the low oxygen group when compared to the control. 
Decorin is a small proteoglycan that binds transforming growth factor-beta (TGF-beta) 
inhibiting TGF-beta activity in the ovary [125].  Decorin helps regulate cell growth within 
preantral follicles by participating in a negative feedback system to control TGF-beta activity 
[125].  Contrary to follistatin, decorin was downregulated in the high oxygen group compared to 
the control.  This may result in an abnormally high level of TGF-beta activity within these 
preantral follicles.  Decorin was not found to be differentially expressed in the low oxygen group 
when compared to the control.      
5.3.2.2 Steroidogenesis 
In both the high and low oxygen groups, cytochrome p450 family 17 subfamily A 
polypeptide 1 (Cyp17A1) was downregulated compared to the in vivo control group.  The 
Cyp17A1 gene is expressed by the theca cells and encodes for the enzyme steroid 17-alpha-
hydroxylase [121].  This enzyme catalyzes the hydroxylation of progesterone or pregnenolone 
along with the cleavage of a two-carbon side chain resulting in the formation of androstenedione 
or dehydroepiandrosterone.  As a result, this is a critical enzyme that properly maintains the 
androgen supply that is utilized for estrogen synthesis [121].  By downregulating the expression 
of this gene, estrogen levels could be reduced, limiting the availability of estrogen to the 
developing follicles. 
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In addition to Cyp17A1, it was discovered that two other genes responsible for regulating 
steroidogenesis, apolipoprotein-E and insulin-like growth factor binding protein 7 were also 
downregulated in follicles in the high oxygen group, but not in follicles from the low oxygen 
group.   
Similar to Cyp17A1, apolipoprotein-E is also expressed by the theca cells.  This protein 
then acts in an autocrine manner in order to regulate androgen production within the theca cells 
[126].   
Insulin-like growth factor binding protein 7 is expressed in the granulosa cells.  Although 
the role of insulin-like growth factor binding protein 7 has not been elucidated in regards to 
preantral follicle development, it has been found to negatively control the steroidogenesis of 
granulosa cells in more mature follicles [120].  By functioning in this capacity, it is believed that 
this protein serves to sustain proper steroid levels within the follicle.   
5.3.2.3 Carbohydrate Metabolism 
Carbohydrate metabolism in ovarian follicles is consistent with cells possessing adequate 
proliferative potential [127].  Granulosa cells in every stage of follicle development produce 
lactate as the major product of follicular carbohydrate metabolism [128].  It has been theorized 
particularly for preantral follicles without a vascular supply that the majority of oxygen is 
consumed in the outer cells of the follicle and that little if any oxygen actually diffuses to the 
interior region of the follicular unit [129].  Therefore, this would create an anaerobic 
environment and drive the formation of lactate.  However, it has been discovered that 
monolayers of granulosa cells cultured in an aerobic environment still produced significant 
quantities of lactate [130].  As a result, it is believed that these cells produce the lactate because 
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it is the most efficient method for providing the considerable quantity of ATP necessary for rapid 
growth rates [129].   
With the significant concentration of FSH facilitating granulosa cell proliferation present 
in both the high and low oxygen culture conditions, it was not surprising that several genes 
involved in carbohydrate metabolic pathways, such as lactate dehydrogenase A and 
glyceraldehydes-3-phosphate dehydrogenase, were found to be upregulated in both the high and 
low oxygen groups.  By administering a relatively high concentration of FSH compared to the 
level experienced by preantral follicles in vivo, the granulosa cells in the cultured preantral 
follicles in both the high and low oxygen group proliferated at a more rapid rate, increasing the 
cell’s ATP requirements.  As a result, the glycolysis rate increased, driving the expression levels 
of genes that participate in carbohydrate metabolism higher.    
5.4 CONCLUSIONS 
At the onset of this chapter, it was suggested that the low oxygen group would have a gene 
expression pattern that more closely resembled the gene expression levels for the in vivo control 
than the high oxygen group.  This hypothesis was based on the results from Chapter 4 that 
showed a significant increase in oocyte viability and maturation when follicles were cultured in a 
dynamic oxygen environment than if they were cultured in an ambient oxygen environment.  
Although, it was also recognized that when compared to the in vivo control oocytes from Chapter 
4, there was a significant decrease in oocyte viability and maturation for both the dynamic 
oxygen group and the ambient oxygen group.   
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As expected, several genes in both the high and low oxygen groups were found to be 
differentially expressed when compared to the in vivo control.  However, when the correlation 
plots for the low oxygen group vs. the in vivo control and the high oxygen group vs. the in vivo 
control were compared, it was found that the low oxygen group displayed a better correlation to 
the in vivo control than the high oxygen group.  The difference between the R2 values was small, 
but it was consistent, remaining robust to several different normalization methods.  This supports 
the conclusion that the difference is due to biological variations. 
By analyzing the individual genes that were differentially expressed in both culture 
groups compared to the control, it was uncovered that both the low oxygen group and the high 
oxygen group differentially express genes that control three crucial processes that participate in 
the regulation of follicle development, the differentiation and growth of granulosa cells, 
steroidogenesis, and carbohydrate metabolism.  However, in addition to the two shared genes 
that were differentially expressed in both culture groups, connective tissue growth factor and 
Cyp17A1, the high oxygen group differentially expressed another four genes that had roles in the 
proper differentiation and growth of granulosa cells and the maintenance of appropriate levels of 
steroidogenesis, follistatin, decorin, apolipoprotein-E, and insulin-like growth factor binding 
protein 7.  These additional genes could possibly lead to even further desynchronized preantral 
follicle development. 
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6.0  SUMMARY, IMPLICATIONS, AND FUTURE DIRECTIONS 
6.1 SUMMARY OF MAIN FINDINGS 
The main findings for the entire study are divided below by the specific research aims.  The 
subsequent implications of these findings are presented in the following section 6.2. 
6.1.1 Maintenance and Support of Follicle Structural Integrity 
Previous studies showed that follicles larger than those of a mouse lose three-dimensional 
integrity when cultured on a flat surface.  We hypothesized that, by culturing follicles in a 
suspension culture system, the three-dimensional integrity of the follicular unit would be better 
supported.  Furthermore, the utilization of alginate microcapsules could help maintain proper 
follicle morphology.  In this aim, we studied the effect that structural support, nutrient delivery, 
and mechanical shear stress may have on follicular growth and morphology.  We demonstrated 
that suspension culture in combination with hydrogel microencapsulation maintains follicular 
growth and morphology more effectively than conventional culture in tissue culture wells.  
Follicle flattening is eliminated in both suspension culture systems.  In contrast to static culture, 
follicles are uniformly supported during suspension culture, unable to adhere to a surface, and 
are protected from shear stress when embedded in calcium alginate microcapsules.  In addition, it 
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was discovered that in order for encapsulated follicles to maintain the growth rate of 
unencapsulated follicles, the inclusion of FSH into the scaffold is required. 
6.1.2 Development of a Novel Dynamic Oxygen Environment 
It is likely that in vivo follicles experience a transition from relative hypoxia in early 
development to the high volume of blood flow and oxygen delivery for pre-ovulatory follicles.  
We hypothesized that the difficulty in achieving in vitro oocyte maturation may be due to the 
dysregulation of follicle development by exposure of early stage follicles to inappropriate 
oxygen concentrations.  Therefore, in this aim, we studied the effect that a dynamic oxygen 
delivery protocol that more closely mimicked the oxygen environment of the native ovary would 
have on oocyte viability and maturation.  We found that the dynamic oxygen environment 
produced a significantly higher yield of healthy oocytes than the static control.  More 
importantly, the oocytes from the dynamic oxygen environment were significantly more efficient 
at progressing through germinal vesicle breakdown than their compliments in the ambient 
oxygen group.  Furthermore, the dynamic oxygen group was able to produce oocytes that were 
capable of undergoing parthenogenetic activation and fertilization.   
6.1.3 Preantral Follicle Gene Expression Analysis 
After observing the advantages of culturing follicles in the dynamic oxygen environment as 
compared to the ambient oxygen environment, we hypothesized that by placing the follicles in 
the ambient oxygen group in an environment more suitable to mature graafian follicles, the 
granulosa cells may not differentiate properly, leading to desynchronized follicle development.  
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In this aim, we studied the effect that the oxygen environment had on preantral follicle gene 
expression.  We discovered that follicles cultured in a low oxygen environment have an 
expression pattern that more closely resembles the expression pattern from in vivo control 
follicles when compared with follicles cultured in a high oxygen environment.  Furthermore, it 
was found that in addition to the two shared genes that were differentially expressed in both 
culture groups, connective tissue growth factor and Cyp17A1, the high oxygen group 
differentially expressed another four genes that had roles in the proper differentiation and growth 
of granulosa cells and the maintenance of appropriate levels of steroidogenesis, follistatin, 
decorin, apolipoprotein-E, and insulin-like growth factor binding protein 7. 
6.2 IMPLICATIONS OF MAIN FINDINGS 
6.2.1 Follicle Culture System Development 
The findings in all three aims of this study contribute additional knowledge and scientific 
understanding to the field of in vitro ovarian follicle development, predominantly the 
development of preantral follicles.  The suspension culture and microencapsulation findings 
indicate that the traditional culture of follicles on a flat surface will not adequately support whole 
follicle development for these larger follicles.  When culturing these rapidly growing follicular 
units on foreign surfaces with no three dimensional support, follicles will plate down to the 
surface and disrupt proper structural integrity.  It stresses the need to consider three-dimensional 
support in future culture systems. 
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 The findings from the oxygen tension study reveal the importance of the unique oxygen 
environment experienced by these follicles in the native ovary.  As the field continues to develop 
culture systems to support larger follicles, the delivery of appropriate levels of nutrients such as 
oxygen will become more important.  These findings can be optimized for future culture systems 
in order to deliver the appropriate oxygen levels throughout the maturation of larger follicles.  
This will serve to increase efficiency of producing viable and mature oocytes.  
The results from the gene expression analysis study could have an impact on the growth 
rate of cultured follicles.  One of the most notable findings in this study was the drastic increase 
in carbohydrate metabolism due to the relatively high concentrations of FSH in the culture 
media.  This suggests that the preantral follicles in culture progressed much more rapidly than 
the in vivo control follicles.  Therefore, it is possible that preantral follicle development may be 
better maintained by culturing preantral follicles at low oxygen and FSH concentrations for 
longer periods of time.  By slowing down the growth of the follicles, they may be able to better 
manage their basement membrane integrity and the maturation of the oocyte. 
6.2.2 Fertility Restoration and the Derivation of Embryonic Stem Cell Lines 
As stated in the initial chapter of this study, the overall goal is to develop a culture system that 
has the ability to produce mature oocytes in order to restore fertility and prove that banked 
ovarian tissue could serve as a source for embryonic stem cells.  By demonstrating successful 
fertilizations and parthenogenetic activations, the findings from the oxygen tension study imply 
that the dynamic oxygen culture system is a viable system for both the restoration of fertility and 
the derivation of embryonic stem cell lines.   
 117 
Although the culture system will have to be scaled up to support the needs of the larger 
primate follicles, the concepts discovered in this study will serve as a foundation for proper in 
vitro follicle development.   
6.3 FUTURE DIRECTIONS 
The findings within this study have contributed to the development of a culture system capable 
of producing mature oocytes.  This will provide the basis for future studies involving the 
production of embryos and the derivation of stem cell lines.  Although this study has 
demonstrated proof of principal through the fertilization of these oocytes, the intracytoplasmic 
sperm injection process and subsequent embryo culture must be optimized.  Once the process of 
creating and culturing embryos becomes more efficient, the research can progress to the 
production of live offspring and the derivation of embryonic stem cell lines.  Therefore, the 
future direction of this research is outlined in the following aim. 
 
Future Aim One: Create embryos from in vitro derived oocytes.  
 
In this aim, we will continue to develop the enabling technology of in vitro folliculogenesis to 
the natural end point of embryo derivation. We will address three hurdles limiting the efficiency 
of this process. 
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6.3.1 Future Aim 1.1: Develop intracytoplasmic sperm injection (ICSI) techniques to 
overcome the problem of premature Zona Pellucida hardening in in vitro cultured oocytes. 
By performing ICSI on ovulated oocytes, we will overcome the zona hardening problem 
encountered in most oocyte culture systems.  We have already performed trial studies of this 
technique with our in vitro derived oocytes. Micromanipulation has shown that the zona of our 
oocytes is indeed hardened but is easily broached by the peizo drill. Rat sperm heads can also be 
obtained by cutting with the peizo instrument and then placed into the cultured oocytes. 
Alternately there is another technique we can use to treat Zona hardening.  Fetuin at 
concentrations ranging from 0.1 to 10µg/mL has been shown to reduce zona hardening [131]. 
These same investigators have reported some success in achieving fertilization of in vitro 
matured oocytes incubated with fetuin prior to insemination [131]. 
6.3.2 Future Aim 1.2: Do embryos from in vitro derived oocytes have alterations in gene 
regulation? 
In order to ascertain whether oocytes derived from culture have any alteration that may affect 
embryo quality but not be readily apparent morphologically, we will perform DNA profiling of 
two-cell and blastocyst stage embryos derived in three different ways. We will obtain eggs 
derived in vivo, by dissection of oviducts of animals subject to routine superovulation. These in 
vivo derived eggs will be fertilized either by routine IVF (insemination by placing activated 
sperm in the same culture dish with the ovulated eggs) or by ICSI (intracytoplasmic sperm 
injection). Cultured follicles will be grown, ovulated and matured to the metaphase II stage as 
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described in Aim 1.1 above and in preliminary data section.  Cultured oocytes will be fertilized 
by ICSI. 
6.3.3 Future Aim 1.3: Enhance the efficiency of in vitro-induced oocyte ovulation. 
Follicle stimulating hormone (FSH) and leutenizing hormone (LH) are hormones that are 
secreted into the blood from the anterior pituitary gland.  Rat Follicles have traditionally been 
grown in the absence of LH and in static FSH concentrations that are several orders of magnitude 
above normal serum concentrations.  However, preantral follicles exist in the avascular cortex of 
the ovary. The FSH available to these small follicles would have to diffuse from nearby antral 
follicles that do have a blood supply.  Furthermore, FSH and LH serum levels fluctuate with the 
different days of the reproductive cycle.  Therefore, over the course of development of a follicle 
from primordial to matured graafian follicle, the follicle is subjected to an increasing range of 
FSH and LH concentrations.  Initially, concentrations are low but as vascular supply develops 
around the follicle, it is exposed to the peaks and troughs of FSH and LH fluctuation in the 
serum.  By excluding LH and imposing a static FSH concentration on cultured follicles, 
conventional culture fails to recreate the dynamic FSH environment present throughout the in 
vivo follicle development process. We know that granulosa cells are extremely sensitive to FSH 
concentrations. It is likely that granulosa cells in follicles also respond to variation in 
gonadotopin levels very differently than constant dosing. In our preliminary studies we have 
determined that we have improved survival and growth of follicles in long term culture when 
fresh FSH is added to the cultures every four days in increasingly higher doses. The studies in 
this section with expand on these studies to see if pulsatile FSH delivery that mimics the in vivo 
environment and LH dosing improves the ovulation rate of cultured follicles. 
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6.3.4 Future Aim 1.4: Determine the effect of EGF on the in vitro maturation of rat 
oocytes.  
Our preliminary studies have shown that the oocytes cultured in the suspension culture system 
are able to resume meiosis and progress to metaphase II.  However, the in vitro maturation of 
oocytes to metaphase II must become more efficient for this system to be considered a viable 
solution.  One approach to optimize the in vitro maturation of these oocytes is the addition of 
EGF to the media at the end of the culture.   
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APPENDIX A 
[PATHWAY-EXPRESS ANALYSIS OF DIFFERENTIALLY EXPRESSED GENES] 
The goal was to determine which pathways are impacted by the differentially expressed genes.  
We implemented a pathway level Impact Analysis which was designed to provide both statistical 
and biological significance in the indication of which pathways may be affected by the observed 
changes in gene expression.  The results are summarized as Impact scores and p-values in Table 
7.  Pathway-Express orders the affected pathways in the decreasing order of their expected 
importance for the given condition, renders KEGG pathway diagrams indicating impacted 
components (Figures 37-41).  There were no pathways found to be significantly impacted by the 
differentially expressed genes from the low oxygen group.  Five pathways were found to be 
significantly impacted by the differentially expressed genes from the high oxygen group shown 
in figures 37-41. 
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Table 7: Pathways found to be impacted by the differentially expressed genes from the high oxygen group 
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Figure 37: TGF-beta pathway. 
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Figure 38: ECM-receptor pathway. 
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Figure 39: Focal Adhesion pathway. 
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Figure 40: Alzheimer’s disease pathway. 
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Figure 41: Neurodegenerative disorders pathway. 
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